IMR Press / FBL / Volume 25 / Issue 1 / DOI: 10.2741/4793
AGO unchained: Canonical and non-canonical roles of Argonaute proteins in mammals
Show Less
1 Laboratory of Biochemistry and Molecular Biology, National Cancer Institute, Bethesda, MD 20892, USA
Send correspondence to: Joana A. Vidigal, Laboratory of Biochemistry and Molecular Biology, National Cancer Institute, Bethesda, MD 20892, USA, Tel: 240-760-6691, E-mail:
Front. Biosci. (Landmark Ed) 2020, 25(1), 1–42;
Published: 1 January 2020
(This article belongs to the Special Issue Elucidation of exosomes role in metastasis)

Argonaute (AGO) proteins play key roles in animal physiology by binding to small RNAs and regulating the expression of their targets. In mammals, they do so through two distinct pathways: the miRNA pathway represses genes through a multiprotein complex that promotes both decay and translational repression; the siRNA pathway represses transcripts through direct Ago2-mediated cleavage. Here, we review our current knowledge of mechanistic details and physiological requirements of both these pathways and briefly discuss their implications to human disease.

In Vivo

In 1998, Karen Bohmert and colleagues identified a mutation that pleiotropically affected plant architecture (1). The mutants—with short and pointy cotyledons and narrow rosette leaves—resembled a small squid, and so were named argonaute. Argonaute 1 (AGO1), the target of the mutations, turned out to be one of ten related genes present in the Arabidopsis thaliana genome (2), and the founding member of a large protein family that extends throughout all domains of life.

Argonaute proteins are present in the majority of sequenced eukaryotic genomes (3)—Saccharomyces cerevisiae being one notable exception (4)—but are only sparsely scattered across prokaryotes (3). Eukaryotic and prokaryotic Ago proteins (eAgo and pAgo) share very low sequence identity, and yet their structure and functional features can be remarkably similar. Crystal structures of bacteria (5-7), archea (8), yeast (9), and human Argonautes (10; 11) show all these proteins have a bi-lobed architecture, with one lobe containing the N-terminal and the PAZ (PIWI-AGO-ZWILLE) domains and the other the MID and PIWI (P element-induced wimpy testis) domains (Figure 1a,b). The central cleft formed between the two lobes serves in all cases to accommodate a short nucleic acid guide and its complementary target, with the 3’ hydroxyl group and 5’ phosphate of the guide binding to the PAZ and PIWI domains respectively. The PIWI domain is structurally similar to ribonuclease H and, in catalytic competent Argonautes, contains an RNase H-like active tetrad (9) that catalyzes the cleavage of nucleic acids with extensive complementarity to the guide.

Figure 1

Structure of mammalian Argonaute proteins. (a) Schematic representation of human Ago2, showing the position of functional domains along the peptide sequence. (b) Crystal structure of human Ago2 (10). Protein domains are colored as in (a). In addition, the position of residues important for catalytic activity are highlighted as in panel (c). (c) Schematic representation of all four human Argonaute proteins highlighting the location of amino-acid sequences known to play a role in cleavage competence. The general position of functional domains is shown on top. The specific amino-acid sequences for each of the proteins is are shown below.

Despite the well-conserved structure of the four core domains, their relative positions differ between eukaryotes and prokaryotes, which together with additional structural differences (10)—such as extended loops and secondary structures in the eukaryotic proteins—explain how the same basic structure has acquired distinct properties and functions throughout evolution (reviewed in (12)). Some pAgos for example have higher affinity for DNA than RNA (5; 13) and both DNA and RNA guided prokaryotic Argonautes seem to be involved in simple host-defense systems (3; 14-16) in which catalytically active Agos are able to recognize and cleave foreign DNA as stand-alone proteins (3; 15). In eukaryotes on the other hand, Argonautes recognize exclusively RNA molecules as guides. Eukaryotic Agos do not act in isolation, but instead are imbedded in complex regulatory networks. Within these networks, eAgos interact with a variety of other cellular proteins likely through eukaryotic-specific insertion elements that provide an interaction surface for binding partners (9). Despite relying on the same effector protein, the pathways centered on eukaryotic Agos are far from being homogenous. Instead, they can involve processes as diverse as transcriptional silencing via heterochromatin formation (17) or DNA methylation (18), post-transcriptional RNA degradation via cleavage (19) or deadenylation (20), as well as translational inhibition (21). The diversity of the pathways is also the result of a variety of sequence adaptations that alter the protein’s properties and its binding to accessory proteins (12).

Eukaryotic Argonautes can be divided into two major and presumably paralogous, clades. The AGO clade comprises proteins homologous to Arabidopsis thaliana AGO1 and are involved in post-transcriptional RNA silencing processes that are relatively ubiquitous in most organisms (22; 23). The PIWI clade comprises proteins related to the Drosophila melanogaster Piwi that play crucial roles in silencing transposable elements in the germline (24). Members of the AGO and PIWI clades are represented in the majority of the eukaryotic supergroups (25; 26), suggesting that they originated from a duplication that predated the last common eukaryotic ancestor (12). Given that Dicer-like proteins and RNA-dependent RNA polymerases (RdRP)—which with eAgos constitute the core eukaryotic RNA interference (RNAi) machinery—show a similarly widespread taxonomic distribution, it seems likely this ancestor already had a fully functional RNA interference machinery (25). The role of this ancestral machinery is unknown but given that it has been lost multiple times during evolution it is likely that it was not essential to life (25). The prevalent hypothesis is that, like in prokaryotes, early eukaryotic RNAi was a host-genome defense mechanism against invading nucleic acids, possibly from both viruses (via a cytoplasmic AGO protein) and transposons (via a nuclear PIWI protein) (25). Supporting this notion, these host defense functions remain well represented in current day eukaryotes (27-31) and are still a primary function of PIWI proteins (32)

Even if eukaryotic AGO proteins did start out as part of a defense system against foreign nucleic acids, they have since been co-opted for the regulation of endogenous RNAs. In fact, transcript regulation downstream of AGO has become essential as evidenced by the severity of phenotypes seen when these proteins (Table 1) or components of their pathway (33) are disrupted. Yet, despite their undisputed importance in regulating animal physiology, the details of how these proteins help shape the transcriptome of an organism are not yet fully understood. Here, we discuss the current understanding of gene regulation downstream of AGO proteins with a particular focus on their roles and regulations in the context of mammalian organisms.

Table 1 Argonaute knockout phenotypes in mice
Targeted Genes Modification Tissue/cell type Phenotype Reference
Ago1 Details not published Whole animal Viable. No detailed characterization reported. 239
Ago2 Gene trap insertion downstream exon1 resulting in truncated protein that is 7 amino acids long Whole animal Homozygous animals die before embryonic day (E) 7.5. 269
Ago2 Gene trap insertion into intron 12 which removes most of the PIWI domain. Whole animal Embryonic arrest before E9.5 is accompanied by ectopic Brachyury expression and mesoderm expansion. 270
Ago2 Insertional disruption strategy creating Ago2 hypomorphic allele. The insertion comprised of a duplication of exons 3-6 and a 10kb vector sequence. Whole animal Embryonic arrest around E9.5. Abnormal placental development. Tetraploid aggregation allows embryogenesis to proceed further but does not yield viable embryos. 42,188
Ago2 Conditional knockout via crossing Ago2-floxed mice with Zp3-Cre strain Oocytes Female infertility. Oocytes are able to mature but have abnormal spindles and chromosomal arrangement 192
Ago2 Catalytic inactivation via D598A point mutation in PIWI domain generates Ago2ADH animals. Whole animal Homozygous animals die perinatally. No defects aside from anemia reported. 188,191
Ago2 Ago2 floxed (Ago2fx) and Ago2ADH strains crossed to generate Ago2fx/ADH animals. Recombination of the floxed allele driven by vav1-Cre. Hematopoietic System mice are viable, survive into adulthood, and breed normally but have anemia 191
Ago2 Ago2-floxed and Ago2ADH strains crossed to generate Ago2fx/ADH animals. Recombination of the floxed allele driven by Zp3-Cre. Oocytes meiotic maturation is impaired, with severe defects in spindle formation and chromosome alignment that lead to meiotic catastrophe 193
Ago3 Details not published Whole animal Viable. No detailed characterization reported. 239
Ago4 Floxed Ago4 in which exons 3-17 are excised upon Cre induction Whole animal Males have reduced testis size and lower sperm counts. Failure to silence many sex-linked transcripts, resulting in apoptosis. spermatogonia enter prophase I prematurely 238
Ago1; Ago3 Details not published Details not published Homozygous animals born at sub-Mendelian ratios. Heterozygous animals and surviving homozygous show increased susceptibility to Influenza A viral infection 239

Following the divergence of AGO and PIWI proteins, the AGO clade underwent a significant expansion, particularly in plants and metazoans (34). While S. pombe contains a single AGO protein that mediates both transcriptional and posttranscriptional silencing (35), the Arabidopsis thaliana genome encodes ten different AGOs (2); Caenorhabditis elegans five (36), Drosophila two (37), and mice and humans four (Ago1-4) (26). This expansion of the AGO clade may be associated with further specialization of the proteins. In Drosophila for example, Ago2’s function is required for posttranscriptional gene silencing by siRNAs, while Ago1 is required for gene silencing via the miRNA pathway (38). Arabidopsis thaliana’s AGO1 is also associated to gene silencing by miRNAs (39), whereas AGO4 is involved in DNA and histone methylation (40). Evidence of functional specialization is also observed in mammals where Ago2 is the only member known to have retained catalytic activity and consequently the ability to cleave RNAs that have full complementarity to the bound small RNA guide (41; 42). Curiously, this functional specialization is also reflected in the genomic distribution of the proteins: in both mouse and human, the genes for Ago1, Ago3, and Ago4 are clustered in tandem at a single chromosomal location (chromosome 1 in humans, chromosome 4 in mice), while Ago2 is expressed from an independent locus (chromosome 8 in humans and chromosome 15 in mice). Presumably this is the result of the duplication of an ancestral AGO and subsequent expansion and catalytic inactivation of one of the copies.

Structural and biochemical studies have defined some of the sequence features that have rendered three of the four mammalian AGOs catalytically inactive (43-47). First, endonucleolytic cleavage requires the presence of a complete catalytic tetrad composed of the DEDH motif (where D, E and H refer to aspartic acid, glutamic acid and histidine, respectively) (9). This motif is intact in both Ago2 and Ago3 but has diverged into the inactive DEDR and DEGR motifs in Ago1 and Ago4 respectively (Figure 1c). In addition to loss of the catalytic tetrad, both Ago1 and Ago4 have a short sequence in the PIWI domain that prevents cleavage even when the catalytic tetrad has been restored (43; 45; 47). This sequence—which overlaps with the eukaryotic-specific insertion element known as cS7 (44)—has been narrowed down to the mutation of a phenylalanine to a leucine at position 674 of Ago1 (45) which likely leads to improper orientation of the substrate relative to the catalytic center (44; 45). The same amino acid is mutated into a methionine in Ago4 (Figure 1c). Underscoring the importance of this residue, generating a F676L mutation in Ago2 (which corresponds to position 674 in Ago1) almost completely abolishes its cleavage ability (45). Prolines at position 670 and 675 in Ago1’s cS7 element may also contribute to cleavage inhibition by making the element protrude into the nucleic-acid-binding channel (44; 45). Likewise, an insertion element near the catalytic residue E629 of Ago4 further contributes to cleavage inactivity likely by misplacing catalytic residues relative to the RNA substrate (47) (Figure 1c).

Unlike Ago1 and Ago4, Ago3 contains a PIWI-domain that is fully competent for cleavage (43-45). Yet, this protein remains catalytically inactive in vitro suggesting that additional structural elements outside the PIWI domain are critical for endonucleolytic activity. At least two such elements seem to reside at the N-terminus of the Ago2 protein (43; 45-47) (Figure 1c). The first element (NT1) has been lost in all three catalytic dead proteins and lies within amino acids 44 and 48 of Ago2 (46; 47). Mutational swap experiments between Ago2 and Ago3 suggest that the methionine at position 47 is the critical residue in this region required for cleavage (46). A second element (NT2) has been lost only in Ago3 and Ago4 (43; 45-47) and has been narrowed down to the minimal region between residues 137 and 150 on Ago2 (47) (Figure 1c). That the N-terminus of the protein influences target cleavage is not entirely unexpected given that the N-PAZ lobe has also been shown to affect slicing activity in Drosophila melanogaster (48) and that the N-terminal domain of Ago2 has been implicated in both RNA duplex unwinding and passenger-strand cleavage (49). What is surprising is that Ago3 has conserved a catalytically competent PIWI domain despite its apparent inability to cleave targets in vitro. One tantalizing possibility is that cleavage by Ago3 is regulated in vivo by a yet unidentified binding partner whose interaction with Ago3 elicits conformational changes that correctly align the target RNA with the catalytic tetrad (43; 46). Alternatively, it is possible that the cleavage activity of Ago3 has so far been overlooked because its substrate requirements happen to be distinct from those of Ago2, and thus not often met by in vitro cleavage assays (50).

Regardless of the structural features that make each protein unique, all mammalian Argonautes are able to engage in target repression via the microRNA (miRNA) pathway, in which a short-stretch of sequence complementarity between guide and target leads to target repression via mRNA decay and/or translation inhibition. Ago2 can also associate with endogenous small-interfering RNAs (endo-siRNAs) whose extensive complementarity to a target induces cleavage via the protein’s catalytic domain. Though largely different in their cellular origin and mode of action, both pathways seem to be essential to life through processes that are often intertwined in mammals.


MiRNAs and endo-siRNAs are the main small RNA partners of AGO proteins in mammals. They both share a final biogenesis step in which Dicer cleaves double-stranded precursors into small RNA duplexes just prior to them being loaded into Argonaute to act as guides. And yet, despite this common step, the upstream processes that generate the two Dicer substrates are largely different.

MicroRNAs are by far the best characterized guides for AGO proteins in metazoans. They are transcribed by polymerase II as long “primary miRNA transcripts” (pri-miRNAs) that like messenger RNAs are both capped and polyadenylated. Pri-miRNAs contain a characteristic hairpin secondary structure that—generally speaking—is cleaved in the nucleus by the microprocessor complex, containing a single Drosha protein and two molecules of its cofactor Dgcr8. Cleavage by the microprocessor at the base of the hairpin releases a precursor (pre-miRNA) of about 60-70 nucleotides in length (51). Given that pri-miRNAs can have very diverse sequences it has not always been clear how they are specifically recognized by the microprocessor or how it determines the precise location of the cut. It turns out that pri-miRNAs share common structural features that dictate how processing occurs (52). For one, the stem of the hairpin is an imperfectly complementary double-stranded structure of approximately 33 base pairs in length flanked by two stretches of single-stranded RNA (ssRNA) at the base, and a ssRNA loop at the apex. Drosha recognizes the basal junction between the ssRNA segments and the double-stranded RNA (dsRNA) stem and, as long as the pri-mRNA is properly folded, can on its own faithfully cleave the RNA eleven base-pairs away from the junction. Yet, it’s only in the presence of Dgcr8 that this activity becomes efficient. Dgcr8 binds as a dimer to the apical junction where the double-stranded stem meets the ssRNA loop (52). In addition, it interacts with Drosha via the C-terminal tail, stabilizing the association of the endonuclease with the RNA. Small primary sequence motifs at both the basal and apical ends may also strengthen the binding of both proteins to the pri-mRNA and confer asymmetry to the association (52). Once the hairpin is released, it is shuttled into the cytoplasm by Exportin-5 and RAN-GTP (53) where it is further processed by Dicer to generate the 20-24 nucleotide-long (nt) miRNA duplex (54) that gets loaded into an Argonaute protein. Like Drosha, Dicer binds to its substrate in a sequence-independent manner and acts as a “molecular ruler” cutting the double stranded molecule at a defined distance from its terminus. Both enzymes cleave the RNA via RNase III domains and thus their sequential activity generates a molecule with the typical 2-nt 3’ overhang at both ends.

Like miRNAs, endo-siRNAs are small endogenous RNAs—approximately 20-26 nucleotides in length—generated through Dicer cleavage. But unlike miRNAs their biogenesis is independent of the microprocessor complex in the nucleus (55). In fact, instead of being derived from precursors with the typical short hairpin stem loop, endo-siRNAs are processed from long dsRNAs whose origin and biogenesis can vary widely between species. Indeed, for a long-time endo-siRNAs were only detected in organisms that possess RNA-dependent RNA polymerases (RdRPs) Caenorhabditis elegans (56; 57) and fission yeast (58). In these organisms, RdRPs play a critical role in the biogenesis of the small RNAs and in the amplification of the RNA interference response. RdRPs transcribe single stranded RNA (ssRNA) using the target RNA as a template. This generates an abundant pool of endo-siRNAs. Because flies and vertebrates do not encode RdRPs, it was generally assumed that they lacked this class of RNAs. This paradigm shifted when a series of studies reported the identification of siRNAs mapping to endogenous loci in both flies and mice (59-62) showing that they could also be produced in the absence of RdRPs. But even between flies and mammals, the details of the pathway seem to be distinct. In Drosophila, although both miRNAs and siRNAs are processed by Dicer and loaded into AGO, they do so through parallel arms of the RNAi machinery. Flies have two distinct Dicer isoforms and two genes encoding for AGO. While Dicer-1 processes precursor miRNAs that are loaded into Ago1, Dicer-2 processes long double-stranded RNAs into siRNAs duplexes that get loaded into Ago2 (63). This segregation of the pathways makes the study of their details and functions more tractable in flies (38). As a consequence, endo-siRNA biogenesis and functions are better understood in flies than mammals. We know that in flies double stranded RNAs precursors of siRNAs can be produced by at least two distinct mechanisms. They can originate from bidirectional transcription from a single locus which gives rise to RNAs known as cis natural antisense transcripts (cisNATs) (59; 61; 64; 65), or from structured loci that are transcribed as long hairpin RNAs (hpRNAs) (60). The functions of these precursors are not entirely understood, but they have been predominantly implicated in genome protection against foreign nucleic acids. Indeed, mutant flies in which the endo-siRNA pathway is specifically impaired cannot efficiently defend against transposable elements (66). Compromising the siRNA pathway in flies seems to be compatible with animal viability, but it affects spermatogenesis both in D. melanogaster (leading to animals that are subfertile) (67) and D. simulans (which become fully sterile) (68). In both cases, the phenotypes have been linked to transposon up-regulation.

As in flies, cisNATs (62; 69) and hpRNAs (62; 69) have also been suggested to serve as endogenous sources of siRNA precursors in mammals. In addition, precursors can be generated through the interaction between complementary transcripts derived from distinct loci such as gene-pseudogene pairs (transNATs) (62; 69). Mammalian endo-siRNAs have also been predominantly mapped to repetitive sequences, most of which are transposons. Yet, to what extent these siRNAs contribute to transcript silencing is not clear. For one, long double stranded RNA molecules—such as those that serve as siRNA precursors—are known to be strong triggers of the interferon response (INF) in vertebrates (70). As a consequence, in the majority of cells, they are not expected to accumulate to high-enough levels to significantly impact the transcriptome (71; 72). In addition, in most tissues, transposons are silenced via promoter methylation. Thus, it seems that even if endo-siRNAs did arise as a way to restrict foreign nucleic acids, this function has since become ancillary to other mechanisms. In line with this, endo-siRNA detection in mammals has been restricted to situations in which there is low interferon response or DNA methylation is reduced (73-78).

An additional roadblock for the production of endo-siRNAs in mammals is the fact that their Dicer protein is much more efficient at processing pre-miRNAs than the long dsRNAs that serve as precursors for siRNAs (79). This is likely caused by the N-terminal helicase domain which disturbs the RNase III catalytic core and inhibits the cleavage of perfect dsRNAs (80). In fact, murine oocytes—where mammalian endo-siRNAs have been best characterized—express an N-terminally truncated isoform of Dicer transcribed by an alternative promoter derived from a transposon insertion. This shorter isoform can process dsRNAs into siRNAs more efficiently than somatic dicer (81) but is rodent specific (82) and so its functions cannot serve as a model to understand the siRNA pathway in other mammals.


Whether they originate from pri-miRNAs or dsRNAs, products of Dicer cleavage are ultimately loaded into AGO proteins (83-87) with the assistance of the ATP-dependent activity of Hsc70/Hsp90 (88-91). These chaperons are thought to mediate a conformational change in AGO, making the nucleic acid-binding channel wide enough to accommodate the bulky and rigid duplexes. Once AGO returns to its closed conformation however, the channel is no longer able to lodge such large molecules. This presumably helps in the expulsion of one of the strands without further need for ATP consumption (92). When that happens, the strand whose 5’ end is tightly anchored in the PIWI domain remains associated with the protein to act as a guide, while the other is discarded (93). Because of this, the orientation by which the duplex is incorporated into an AGO protein determines which strand will serve as a guide. Studies in a variety of model organisms show this is a non-random process (94; 95). At least two sources of asymmetry in the duplex contribute to a loading bias: the identity of the 5’ nucleotide in each strand, and the relative thermodynamic stability of the 5’ ends. As a general rule, the strand with the most unstable 5’ terminus will be preferentially selected for loading into an AGO protein (94).

In Drosophila melanogaster, where the mechanism of AGO loading has been best characterized, Dicer itself is involved in the process. Following cleavage of the dsRNA molecules, Dicer-2 associates with R2D2 (96) to form a RISC Loading Complex (RLC) (97) that is essential for the incorporation of siRNAs into Argonaute (98). Within the RLC, R2D2 binds the strand that has the most thermodynamically stable 5’ end (99), and thus is responsible for orienting the RNA molecule within the complex. R2D2 also requires the presence of a phosphate group at the 5’ end for binding, thus ensuring that only true siRNAs are able to enter the RNAi pathway (99). Both R2D2 and Dicer-2 participate in the unwinding of the siRNA duplex (99; 100), at which point the heterodimer is exchanged by Ago2. When that happens, the strand that was bound by R2D2 is discarded while the one that was bound by Dicer gets incorporated into Ago2 (101). Because the RLC plays a role in the asymmetry sensing of the duplex, it is also responsible for the selection of the strand that ultimately acts as a mature siRNA. In the absence of Dicer-2 or R2D2, silencing of transcripts via the siRNA pathway proceeds inefficiently, even when cells are provided with external pre-processed siRNA duplexes (96; 100; 102).

In contrast to Drosophila’s Ago2, vertebrate AGO proteins do not require Dicer for small RNA loading. In fact, Dicer is dispensable for asymmetry sensing in mice (103), and Dicer-null mouse embryonic stem cells are fully competent in gene silencing by exogenous siRNAs (104; 105). Human Ago2 can also be loaded with siRNAs in vitro in the absence of additional factors (106), and even zebrafish embryos lacking Dicer can fully repress targets when injected with miRNA duplexes (107). In this regard, vertebrate AGOs are more related to Drosophila’s Ago1, whose loading is also unaffected by the absence of Dicer proteins (86). Thus, although it is the best-characterized, the process of Ago2 loading in flies seems to be a rather unique case that cannot be fully generalized to other species. It is worth noting that in mammals, two Dicer partners have been identified: TRBP and PACT (108-113). The TRBP/PACT homologue in flies is known as Loquacious (Loqs or R3D1), and it binds specifically to Ago1 (114-116). Though neither of these proteins are essential for AGO loading, DICER-TRBP, and Loqs-Dicer complexes have also asymmetric association with RNA duplexes (117; 118), suggesting that they may help reinforce other asymmetry sensing mechanisms.

But what might the nature of those mechanisms be? It seems that, at least in part, they depend on the structure of the AGO itself, and particularly its interaction with the 5’ end of the guide. The importance of the 5’ end for the function of miRNAs is more than well established. MicroRNAs recognize their targets via complementarity to the seed sequence, a stretch of 6 nucleotides (nucleotides 2-7) at the 5’ end of the miRNA (22). Mature miRNAs may originate from either arm of the pre-miRNA hairpin and consequently can have their seed defined by both Drosha/Dgcr8 or by Dicer cleavage. Because these processes have varying degrees of precision (119; 120), an additional checkpoint at the time of AGO loading further increases targeting accuracy. In practice, this is achieved through preferential loading of miRNAs that have an A or a U as their terminal 5’ nucleotide. Crystal structures of Ago2’s MID domain in complex with all four nucleoside monophosphates show that this selection depends on a structural loop that leads to nucleotide-specific interactions in the MID domain that specifically exclude G or C (121). The “specificity-loop” is present in all four human Argonautes as well as Drosophila’s Ago1, but it is absent from Drosophila’s Ago2 (121), which instead has bias towards a 5’ terminal C (59; 122; 123).

An additional conundrum in mammals is how sorting of small RNAs among the four Argonaute proteins is achieved, if at all. Though exceptions have been described (124), miRNA-mediated gene regulation does not typically require cleavage and can therefore be carried out by all four proteins. In contrast, endo-siRNAs are thought to regulate RNAs through catalysis, meaning that productive targeting requires them to be loaded specifically into Ago2. Yet, in jarring contrast to what happens in Drosophila (125; 126), there is little evidence that such discrimination occurs in mammals, and both miRNAs (127) and exogenous siRNAs (128) are randomly distributed among individual proteins. This could reflect Ago2’s predominant expression across many tissues, which could render a sorting mechanism unnecessary. Alternatively, endo-siRNAs may have features not recapitulated by artificial siRNAs that lead to preferential loading into Ago2. In fact, miR-451 whose last processing step is mediated not by Dicer but by Argonaute, associates exclusively with Ago2, suggesting that such discrimination is possible (129).


Once AGO proteins are loaded and the passenger strand discarded (94), they are directed to target transcripts via complementarity to the guide. For miRNAs, specificity is predominantly defined by the seed-sequence (130), and this motif is short enough that a single miRNA can direct AGO to hundreds of messages. Seed-matches can occur across the entirety of the transcript, and indeed RNA fragments that crosslink to Argonaute can map to all features of an mRNA (131; 132). Despite this, the majority of targeting is mediated by sites in the 3’ untranslated region (3’UTR) (22), where there is no risk of displacement of AGO by a traveling ribosome. Following miRNA:mRNA pairing, assembly of the RNA-induced Silencing Complex (RISC) leads to target repression via a combination of mRNA destabilization and translation inhibition (133; 134). At the center of this complex, is a family of proteins known as GW182 that act as platforms between AGO proteins and downstream effector proteins.

GW182 proteins are an innovation of metazoans (135). This protein family is characterized by the presence of multiple tryptophan-glycine motifs (GW), which serve as an interaction surface for its binding partners (136). Drosophila melanogaster has a single member of this family (GW182), but vertebrate genomes encode three paralogues: TNRC6A/GW182, TNRC6B, and TNRC6C (137). Although plants do not seem to have a GW182 ortholog per se, translational repression downstream of miRNA targeting (138-142) may also depend on a GW-repeat protein called SUO (142). GW182 proteins contain two functional domains: the AGO-binding domain (ABD), and a C-terminal domain (comprised of PAM2 and RRM motifs) that mediates the binding to components of the silencing machinery (143). Within the ABD, three single motifs—with tandem GW/WG repeats spaced by 9-20 residues—have been shown to interact with human Argonautes (144-147). While GW182 proteins can recruit up to three copies of AGO through these motifs, each Argonaute can only bind to a single GW182 molecule (148). It does so through two tryptophan-binding pockets in the PIWI domain that fit consecutive residues as long as they are at least 10 residues apart (10). These binding pockets are conserved among AGOs that participate in the miRNA pathway (Ago1-Ago4 in mammals, Ago1 in flies), but not in Drosophila’s Ago2 (84). Accordingly, a GW182-derived short peptide containing one of the GW motifs can efficiently precipitate all mammalian AGOs, Drosophila’s Ago1, and even some plant AGOs, but not Drosophila’s Ago2 (149). Binding affinity of AGO towards GW182 increases greatly when the protein is loaded with a small RNA (148). Given that target recognition of a loaded Argonaute occurs almost instantaneously (150), assembly of RISC likely happens once AGO is already sitting on its target. Due of its flexible nature, GW182 can bind to multiple target-bound Argonautes (148), which may help stabilize interactions, leading RISC to associate longer with individual mRNAs (151) and thus be more effective in repressing their expression. Thus, the multivalent binding of GW182 to AGO may underlie the earlier observations of cooperative regulation by adjacent miRNA binding sites (152-156).

GW182 also serves as a docking site for proteins that ultimately repress the expression of miRNA targets. The molecular details behind this repression have been intensively studied and yet they remain a source of debate (156). One problem is that the factors involved in silencing are able to associate through promiscuous binding (23) in a variety of combinations that have largely redundant functions. These redundant assemblies of RISC offer many alternatives through which to silence gene expression, and thus may serve as a way to confer robustness to the process. One of the best understood—and arguably the most ubiquitous—consequence of miRNA targeting for example is mRNA deadenylation, which ultimately leads to transcript decay. At least two deadenylase complexes have been implicated in this process: the PAN2-PAN3 and CCR4-NOT (157-159). Both bind to GW182 via the tryptophan residues (160-162), but their relative contribution to decay is not entirely clear. In fact, it is possible to remove the PAN complex or outcompete its catalytic component without impacting RISC silencing efficiency (163; 164), which suggests compensation between the complexes (23). GW182 also interacts with the cytoplasmic poly(A)-binding protein (PABPC) (165), which in turn binds to PAN3 (159; 166). How PABC contributes to silencing is unclear, but it may help stabilize the interaction of RISC with polyadenylated RNAs (167). its depletion does not however, inhibit silencing in a number of contexts (168; 169) suggesting that this interaction may constitute yet another example of functional redundancy. Regardless of which complexes are involved in the deadenylation, once a poly(A) tail has been sufficiently shortened, mRNAs are decapped thereby committing them to full 5’ to 3’ degradation by XRN1 (20; 170). The CCR4-NOT complex seems to be an important scaffolding component in this process as well, by serving as a binding platform for decapping factors (161; 162). In addition to deadenylation, decapping, and decay, miRNA-mediated silencing can also repress genes by inhibiting translation. In fact, time course experiments using ribosomal profiling suggest that this is the first measurable consequence miRNAs have on the expression of their targets (171; 172). Nevertheless, across cell lines and miRNA species, by the time full repression has been established the majority of the silencing is achieved through decay, with a minor component being attributed to translation repression (171; 172). The molecular details behind translational inhibition are much less understood than those behind degradation, but accumulating evidence suggest that miRNAs interfere with the function of the eIF4F complex (23). The CCR4-NOT complex seems to play a role by serving as a docking platform for proteins such as DDX6 (161) and eIF4A2 (173), both of which repress translation through poorly understood mechanisms. PABPC has also been implicated in translation repression, again through unclear mechanisms.

Given that the majority of the details described above have been elucidated in cell culture, a key question is to what extent do they reflect in vivo processes and dynamics. We know that at least in early zebrafish development—in stark contrast to what is seen in tissue culture—repression of miRNA targets occurs almost exclusively through translation inhibition (21; 174). This has been assumed to be a peculiarity of early embryogenesis. But, given the scarcity of in vivo data, it may turn out that this mode of silencing plays bigger roles in animals than is currently appreciated. In fact, gel filtration experiments suggest the existence of largely distinct forms of RISC in vivo and in vitro with AGO eluting in high-molecular weight fractions in cell lines, and in low molecular weight fractions in the majority of adult mouse tissues (175). Shifting from high to low molecular weight RISC is regulated at least in part by the PI3K–AKT–mTOR signaling pathway, whose activity increases the translation and abundance of GW182 proteins (175-177). AKT also phosphorylates Ago2 at S387, facilitating its interaction with GW182 (178). Together, these observations suggest that in high-proliferative cells, mitogenic signals may lead to the assembly of high-molecular weight complexes through two parallel strategies that promote the association of AGO to GW182. It is worth noting, that absence of this interaction does not necessarily mean loss of miRNA-mediated repression. In insect cells for example, pure translation repression occurs even in the absence of GW182 (179). Nevertheless, in mouse adult tissues, low molecular weight RISC seems to correspond to Argonaute bound only to a small RNA (175; 176). What role it plays there in the absence of interactions with effector proteins remains to be seen.


Although silencing of transcripts by miRNAs requires the assembly of a RISC complex, cleavage of transcripts via Ago2’s catalytic domain (Figure 1) does not seem to need any accessory proteins. In fact, the only two elements required to induce cleavage in vitro are the recombinant Ago2 itself and a single-stranded guide RNA that is generally referred to as small-interfering RNA (siRNA) (180). In contrast to miRNAs, siRNAs bind to their targets with full complementary and cleave them in a Mg2+ dependent manner (180; 181) at the position opposite to nucleotides 10 and 11 of the guide (182). An siRNA loaded into Ago2 but not paired with a substrate has its 5’ end bound to the MID domain (183) and its 3’ end anchored to the PAZ domain (6). Once pairing to the target occurs, the 3’ end is released from the PAZ domain leading to a catalytic competent complex (7; 184). In Drosophila, where Ago2 has specialized in transcript repression via the siRNA pathway, the extensive complementary between guide and target slows the rate at which this complex is formed and dissociated. In practice, these slow dynamics mean that essentially every fully-paired target is more likely to get cut than released (150). In contrast, murine Ago2—which acts both in the miRNA and the siRNA pathways—is able to dissociate rapidly and with similar rates for fully-paired and seed-matched targets, meaning that fully-complementary transcripts often get released before cleavage can occur (150).

Despite the accumulating evidence pointing to a rudimentary and inefficient siRNA pathway in mammals, knockout models for Dicer show more severe phenotypes than those with a deletion of Dgcr8 (Figure 2). This suggests that regulation of transcripts by siRNAs may still be physiologically important. Mouse embryonic stem (ES) cells null for Dicer for example, proliferate slower than their wild-type counterparts and are unable to differentiate (104). In vivo, these phenotypes translate to a reduced pool of pluripotent cells in the blastocyst’s inner cell mass and embryonic lethality before the body plan is established at gastrulation (185). In addition, mouse oocytes without Dicer arrest at meiosis I, with defects in spindle organization and chromosome alignment (186) (Figure 2). Dgcr8-deficient ES cells also proliferate slower, yet they are able to upregulate lineage markers when induced to differentiate, even if they cannot fully silence pluripotency genes (187). In addition, although embryos that lack Dgcr8 also die around gastrulation (187), their blastocysts can be used to establish in vitro ES cell cultures (187) unlike those from Dicer-/- (185). Finally, Dgcr8 is fully dispensable to oocyte maturation (75) in mice.

Figure 2

Summary of developmental phenotypes observed in mice carrying targeted deletions of components of the miRNA and siRNA pathways. The small RNA pathways that are affected in each genotype are shown on top. Briefly, in the absence of Dgcr8 oocytes mature normally, but loss of Dicer, Ago2 or Ago2’s catalytic activity leads to arrest at meiosis I accompanied by spindle and chromosome segregation defects. At the blastocyst stage, pluripotent cells (pink) are specifically depleted from Dicer-/- embryos. Dgcr8-/- and Ago2-/- have a relatively normal pre-implantation development, but like Dicer-/- embryos do not survive past gastrulation. Finally, animals expressing the catalytic dead Ago2ADH survive up to birth but succumb soon after. #, in Ago2-/- animals the miRNA pathway is impaired but not fully disrupted because the redundancy with other Argonaute proteins; ‡, the presence of pluripotent stem cells in the blastocyst of Ago2-/- mice has not been characterized but is assumed here to be intact based on the phenotypes of ES cells (268); *, three knockout models for Ago2 have been described showing embryonic lethality at different stages. Here we are representing only the most severe phenotype leading to embryonic lethality around gastrulation (see Table 1 for more details).

If this discrepancy of phenotypes caught people’s curiosity, the perinatal lethality of catalytic-dead Ago2 animals got everyone’s attention (188). Mice carrying a point mutation that converts Ago2’s catalytic tetrad from DEDH to AEDH (commonly referred as Ago2ADH animals) are born at Mendelian ratios but die soon after birth (188) (Figure 2, Table 1). Since this modification renders the protein catalytic inactive but does not affect its ability to bind to small RNAs (42), the perinatal lethality seems due solely to loss of transcript cleavage by Ago2. The most obvious phenotype these animals have at birth is a strong anemia caused by a block in the proerythroblast to basophilic erythroblast transition (42). It turns out that Ago2 is required for the maturation of two different miRNAs that play a role in this process. miR-451 is an erythroid-specific miRNA whose activity is important for erythrocyte maturation (189), but that cannot be processed by Dicer due to an unusual stem-loop structure. In mice and zebrafish this function is instead performed by Ago2, which binds to the pre-miR-451 and cleaves it at the thirtieth base generating the miRNA duplex (188; 190). In mice, a second erythroid microRNA, miR-486, can be efficiently processed by Dicer but requires cleavage of its passenger strand by AGO2 to generate a mature miRNA (191). Double knockout animals of miR-451/miR-486 display a strong anemia (191) that phenocopies the conditional loss of Ago2’s catalytic activity in the hematopoietic system (191) (Table 1). However, these animals are viable indicating that in mice, Ago2 mediated cleavage plays other roles beyond erythropoietic miRNA biogenesis.

Apart from erythrocytosis and fetus viability, Ago2’s catalytic activity is also required for oocyte maturation as had been previously hypothesized (Figure 2, Table 1). Indeed, as in the case of Dicer, deletion of Ago2 from the female germline leads to animal infertility (192) and this phenotype is recapitulated in Ago2ADH animals (193). Also here, the infertility is caused by severe spindle formation and chromosome alignment defects leading to oocyte arrest at meiosis I (193). Dicer ablation in the oocyte leads to upregulation of a number of RNAs including mRNAs and retrotransposons (186), but these have no sequence matches for the most abundant miRNAs present the cell. Instead, they seem to be silenced by endo-siRNAs which are highly expressed in the oocyte (194). Given that mouse oocytes express a murine-specific isoform of Dicer that is particularly efficient at processing endo-siRNAs (81), it is unclear to what extent these phenotypes highlight a conserved a function for Ago2 in oocyte development. Nevertheless, transposon de-repression and chromosome segregation defects have been reported in a number of other systems that do not express this specialized Dicer isoform including mouse embryonic stem cells (104), mouse preimplantation embryos (195), mouse retina (196), and even human cells (197; 198). Mitotic chromosomal defects have been attributed to a need to control the levels of α-satellite RNA through Ago2 mediated cleavage so that proteins such as centromere protein C1 (CENPC1) can properly localize to centromeric regions (197). Although de-repression of these RNAs has been described in mouse and human cell lines following Dicer or Ago2 depletion (104; 197), it has not been described in oocytes.

Finally, Ago2 catalysis has also been implicated in the repression of protein coding genes. In the mouse oocyte, mRNAs upregulated upon loss of Dicer are enriched for the presence of transposon-derived repeat sequences (186), which are thought to serve as targets sites for the endo-siRNAs expressed in the cell. In addition, mRNA cleavage has been reported for a handful of highly complementary miRNA targets (124; 199-201). The most notorious example is Hoxb8, a conserved cleavage target of miR-196 in vertebrates (124; 202). This miRNA is encoded at three paralogue locations within Hox clusters A, B and C (124), and its extensive complementarity to Hoxb8’s 3’UTR leads to detectable cleavage of the transcript in mouse embryos (124). Furthermore, overexpressing miR-196 in zebrafish or inhibiting its function with morpholinos results in skeletal and homeotic aberrations (202). This suggests that cleavage of transcripts by miRNAs may play important functions in vertebrates. Nevertheless, only a few cases of miRNA-mediated cleavage have been described and, for the majority of these, the potential implications for animal physiology are not known.


In mammals, regulation of transcripts by Argonaute proteins has been generally understood to be a cytoplasmic process. Specifically, Argonautes and the transcripts they regulate are known to accumulate in Processing bodies (P-bodies) (203), ribonucleoprotein cytoplasmic granules comprised mainly of proteins involved in RNA decay and translationally repressed transcripts (204). Localization of AGO to P-bodies is readily detectable by immunofluorescence and, for both protein and its target, occurs in a miRNA-dependent manner (203). Over the past years however, a growing number of reports suggest that Argonaute proteins can also be found in the nucleus of mouse and human cell lines (205-208) (reviewed in (208)). The issue of Argonaute nuclear localization in mammals remains somewhat controversial, in part because the antibodies used in these studies are often not thoroughly validated and because the purity of the nuclear subcellular fraction is not always monitored for endoplasmic reticulum contamination. Nevertheless, a significant number of studies have performed both immunofluorescence and cell fractionation experiments using well controlled reagents and protocols giving credibility to the observation that, as in other organisms (17; 209-211), mammalian Argonaute proteins may also have functions in the nucleus.

Given the phenotypes of Ago2-/- oocytes (Figure 2), perhaps one of the most conserved roles of nuclear AGO is ensuring proper centromere function and correct chromosome segregation during cell division. Indeed, chromosomal defects reminiscent of those seen in murine oocytes and human cells are observed in AGO mutants of numerous other species (209; 212-214) and are associated with the presence of this protein in the nucleus. The C. elegans’ catalytic Argonaute CSR-1 for example localizes to P-bodies in developing oocytes. In mature oocytes however, it becomes enriched in the nucleus where it associates with chromosomes (209). In its absence, animals become infertile (215) and display numerous meiotic and mitotic defects (209; 215; 216) including failure to align chromosomes at metaphase and chromosomal bridging phenotypes at anaphase. In addition, retrotransposon control by Ago2 may also require its nuclear localization, as is the case for the Piwi clade (217). It is worth noting however, that while nuclear AGO has been described in mouse ES cells (218)—where centromeric repeats and transposons are de-repressed upon Dicer depletion (104)—it has not yet been described in oocytes where meiotic defects and transposon de-repression in Ago2 mutants have been best described (Figure 2). Other proposed but less characterized functions for mammalian AGO that may require nuclear localization include regulation of splicing (219; 220), as well as gene regulation through transcriptional silencing (221-223) or activation (224; 225). Finally, other components of RISC, such GW182/TNRC6 and members of the CCR4-NOT complex, have also been found in the nucleus (205; 218; 226; 227) where they seem to interact with AGO proteins (205). This suggests that the miRNA pathway itself may be fully functional in this compartment, and in fact, direct targeting of nuclear-retained transcripts by miRNAs has already been reported (218; 228-230).

The mechanism that brings Argonaute into the nucleus is not known. It may however depend on its interaction with the GW182/TNRC6 family of proteins. Inhibiting nuclear export with Leptomycin B in human cells leads to accumulation of TNRC6A and TNRC6B in the nucleus indicating that these proteins typically shuttle between cytoplasmic and nuclear compartments (147). It turns out that members of this family have functional nuclear import (NIS) and export (NES) signals immediately downstream of the GW repeat region (231). Mutating the NES on TNRC6 results in its enrichment in the nucleus, and more importantly also leads to accumulation of Ago2 in this compartment (231). Additional import routes may include Importin 8 (Imp8), which binds to AGO in P-bodies and may help shuttle it to the nucleus (232). Of note, a common prerequisite for AGO and Piwi nuclear localization across species is their loading with a small RNA in the cytoplasm (233; 234; 235; 236), and this may be true for mammalian AGOs as well. Finally, the range of nuclear distributions reported in human and mouse cell lines suggests that the requirement for AGO in this compartment is context dependent as in the case for CSR-1 in C. elegans. Which contexts require mammalian nuclear localization in vivo, or how the abundance of Argonaute proteins between compartments is regulated awaits further studies.


Even if mammalian genomes encode for four distinct AGO genes, the majority of studies querying their functions have focused on Ago2. This is in large part due to the fact that—aside from Ago2’s ability to cleave transcripts—all four proteins seem to have mostly redundant roles in the miRNA pathway. Evidence for redundancy include random loading of miRNAs into AGO proteins (127), and the ability of these proteins to repress similar sets of mRNA transcripts (237). Not only that, reintroduction of any individual proteins into AGO-deficient mouse embryonic stem cells, is sufficient to rescue defects in miRNA-mediated silencing (237) suggesting they are functionally equivalent in this pathway. Nonetheless, we would be remissive if we didn’t point out specific contexts in which other members of this clade have predominant physiological roles, or evidence suggesting that the four mammalian AGO proteins may not be fully interchangeable.

The most obvious way through which different AGO proteins may acquire specialized functions in mammalian physiology is through restriction of their expression. Although the expression patterns of these proteins are not well characterized due to the lack of specific antibodies, it is assumed based on RNA sequencing data that Ago2 is the most abundant member of the clade. This is supported by data from a peptide-based purification approach which suggests that Ago1, Ago2 and Ago3 are broadly expressed across mouse tissues, with Ago2 being generally the most abundant protein, followed by Ago1 and Ago3 (149). Ago4 on the other hand, is virtually undetectable in all tissues except the testes (149), suggesting it may play specific functions in that organ. And in fact, male mice lacking Ago4 are viable but display a wide-range of fertility defects including reduced testis size and lower sperm counts (238) (Table 1). These phenotypes are all the more surprising given that Ago4 is the least abundant Argonaute protein in the testis (149). Ago4 expression is the highest at prophase I where it localizes to the Sex Body, a nuclear structure formed as a result of the meiotic sex-chromosome inactivation, and which allows the unpaired sex chromatin to bypass the meiotic synapsis check points (238). In the absence of Ago4, Sex Bodies have an abnormal morphology and fail to silence many sex-linked genes, resulting in cellular apoptosis (238). In addition, Ago4-/- spermatogonia enter the prophase I prematurely (238). Ago3 is also highly expressed in meiotic cells in the testis, and its abundance increases in the absence of Ago4 suggesting that the two proteins may have partially redundant functions. However, no fertility defects have been reported in Ago3 null animals (239) (Table 1).

Even for co-expressed proteins, functional specification may be conferred through distinct subcellular localizations. As an example, both Ago2 and Ago1 were found in the nucleus of a human cancer cell line (224). Yet, overexpression of HA or GFP tagged versions of these proteins suggest that they may occupy largely distinct regions within the nucleus, with Ago1 being more broadly distributed and Ago2 being restricted to the nuclear periphery (224). In these cells Ago1, but not Ago2, has been reported to interact with RNA polymerase II and bind to promoters and enhancers of actively expressed genes (224), where it is proposed to contribute to transcriptional activation (220; 224). It is not clear how generalizable these observations are, what their physiological relevance is, or which mechanism leads to distinct protein localization within the nucleus.

One possible mechanism through which co-expressed AGO proteins acquire distinct cellular behaviors is through differential binding to interaction partners. We mentioned above that signaling through the PI3K-AKT stimulates the association between GW182 proteins and AGO. One way it accomplishes this is through phosphorylation of Ago2 at S387, which promotes the phosphorylation-dependent binding of LIMD1 (178). Binding of LIMD1 to Ago2 is essential for its ability to repressed targets, presumably because in its absence assembly of the RISC complex is impaired (178). Phosphorylation dependent interaction with LIMD1 is also seen for Ago1 and Ago4 both of which also have a serine at the corresponding amino-acid position. Human Ago3 however, has a phospho-mimetic glutamate at that location (E390) which facilitates the interaction with LIMD1 and its family members independently of AKT signaling (178). Thus, the AKT-AGO-LIMD1 pathway seem to determine context dependent AGO utilization. Why switching to Ago3-mediated gene repression in the absence of AKT signaling would be advantageous is not known.

Perhaps one reason is that, even though all four mammalian proteins can associate with the same miRNAs (127), some level of RNA binding discrimination among all four proteins may exist. One example we previously discussed is the specific association of pre-mir-451 with Ago2 (129). In addition, individual Argonautes show preferential binding to different miRNA and siRNA duplex structures (237). Finally, recent studies suggest that Argonaute proteins can also bind to small RNAs such as tRNA fragments (240; 241), and that these associations can be somewhat protein specific (242). Together, these data suggest that regulation of genes by all four mammalian AGO proteins may not be entirely redundant. In agreement with this, although both Ago1 and Ago2 are equally able to rescue the phenotypic defects of AGO-null ES cells (237), only Ago2—even if catalytically dead—can support their differentiation into extraembryonic endoderm cells in the absence of exogenous delivery of Gata6 (243).


By serving as the central proteins in two distinct small RNA pathways, mammalian AGO proteins regulate virtually every cellular process. It is not surprising then, that their regulation has often been implicated in human disease. The genomic region encoding for Ago1, Ago3, and Ago4 for example is often lost in Wilms' tumors (244; 245), a pediatric kidney cancer that’s amongst the most frequent childhood malignancies in the US (245; 246). In line with a role for miRNAs in the etiology of this disease, whole-exome sequencing efforts have identified recurrent mutations in other components of this pathway including DICER, DROSHA, and DGCR8 (247-250). Wilms’ tumors are thought to arise from abnormal renal development, and indeed Ago1 has a particularly high expression in embryonic kidney suggesting it may play a key role in the differentiation of this organ (251). Germline microdeletions affecting the three non-catalytic AGOs have also been described in patients displaying a range of developmental phenotypes (252). These observations are in line with studies showing that gene regulation by the miRNA pathway is essential for mammalian development.

In addition to disrupting normal developmental processes, AGO deregulation has also been associated to the progression of adult cancers (253-260). Moreover, signaling pathways that are recurrently activated in tumors often lead to post-translational modifications that alter the behavior of AGO proteins. EGFR signaling for example, leads to phosphorylation of Ago2 at Tyr393, which impairs its interaction with DICER and the loading of specific subset of miRNAs (261). This phosphorylation is enhanced under hypoxia conditions and leads to increased cell survival and invasiveness in vitro. It also correlates with poorer prognosis in breast cancer patients (261). AKT signaling which increases miRNA activity through phosphorylation at S387 (262), is also often implicated with tumor development and progression (263).

A key step to understanding how deregulation of AGO proteins contributes to these and other human diseases is characterizing their functions not in cell lines but in the context of an organism. Over the past years, we have gathered a wealth of data characterizing the myriad of ways that RISC complexes can be assembled and how the function of AGO proteins can be regulated through protein modifications (261-267), cellular localization, or binding partners. The next frontier is fitting all these pieces together to see how they contribute to normal mammalian development and physiology and how their disruption affects human health.


We apologize to colleagues whose work could not be cited due to space constraints. We thank Stephen Moore for help editing the manuscript. Our work is supported by the Intramural Research Program of the National Institutes of Health (NIH) and a FLEX grant from the Center for Cancer Research (CCR).

Bohmert K. Camus I. Bellini C. Bouchez D. Caboche M. Benning C. AGO1 defines a novel locus of Arabidopsis controlling leaf development EMBO J 1998 17 1 170 80 DOI: 10.1093/emboj/17.1.170 PMid:9427751 PMCid:PMC1170368
Hunter C. Sun H. Poethig R. S. The Arabidopsis heterochronic gene ZIPPY is an ARGONAUTE family member Curr Biol 2003 13 19 1734 9 DOI: 10.1016/j.cub.2003.09.004 PMid:14521841
Swarts D. C. Jore M. M. Westra E. R. Zhu Y. Janssen J. H. Snijders A. P. Wang Y. Patel D. J. Berenguer J. Brouns S. J. J. Oost J. van der DNA-guided DNA interference by a prokaryotic Argonaute Nature 2014 507 7491 258 261 DOI: 10.1038/nature12971 PMid:24531762 PMCid:PMC4697943
Drinnenberg I. A. Weinberg D. E. Xie K. T. Mower J. P. Wolfe K. H. Fink G. R. Bartel D. P. RNAi in budding yeast Science 2009 326 5952 544 550 DOI: 10.1126/science.1176945 PMid:19745116 PMCid:PMC3786161
Yuan Y. R. Pei Y. Ma J. B. Kuryavyi V. Zhadina M. Meister G. Chen H. Y. Dauter Z. Tuschl T. Patel D. J. Crystal structure of A aeolicus argonaute a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol Cell 2005 19 3 405 19 DOI: 10.1016/j.molcel.2005.07.011 PMid:16061186 PMCid:PMC4689305
Wang Y. Sheng G. Juranek S. Tuschl T. Patel D. J. Structure of the guide-strand-containing argonaute silencing complex Nature 2008 456 7219 209 13 DOI: 10.1038/nature07315 PMid:18754009 PMCid:PMC4689319
Wang Y. Juranek S. Li H. Sheng G. Wardle G. S. Tuschl T. Patel D. J. Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes Nature 2009 461 7265 754 61 DOI: 10.1038/nature08434 PMid:19812667 PMCid:PMC2880917
Song J. J. Smith S. K. Hannon G. J. Joshua-Tor L. Crystal structure of Argonaute and its implications for RISC slicer activity Science 2004 305 5689 1434 7 DOI: 10.1126/science.1102514 PMid:15284453
Nakanishi K. Weinberg D. E. Bartel D. P. Patel D. J. Structure of yeast Argonaute with guide RNA Nature 2012 486 7403 368 74 DOI: 10.1038/nature11211 PMid:22722195 PMCid:PMC3853139
Schirle N. T. MacRae I. J. The crystal structure of human Argonaute2 Science 2012 336 6084 1037 40 DOI: 10.1126/science.1221551 PMid:22539551 PMCid:PMC3521581
Elkayam E. Kuhn C. D. Tocilj A. Haase A. D. Greene E. M. Hannon G. J. Joshua-Tor L. The structure of human argonaute-2 in complex with miR-20a Cell 2012 150 1 100 10 DOI: 10.1016/j.cell.2012.06.021 DOI: 10.1016/j.cell.2012.05.017 PMid:22682761 PMCid:PMC3464090
Swarts D. C. Makarova K. Wang Y. Nakanishi K. Ketting R. F. Koonin E. V. Patel D. J. Oost J. van der The evolutionary journey of Argonaute proteins Nat Struct Mol Biol 2014 21 9 743 53 DOI: 10.1038/nsmb.2879 PMid:25192263 PMCid:PMC4691850
Wang Y. Juranek S. Li H. Sheng G. Tuschl T. Patel D. J. Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex Nature 2008 456 7224 921 6 DOI: 10.1038/nature07666 DOI: 10.1038/454921e
Makarova K. S. Wolf Y. I. Oost J. van der Koonin E. V. Prokaryotic homologs of Argonaute proteins are predicted to function as key components of a novel system of defense against mobile genetic elements Biol Direct 2009 4 29 DOI: 10.1186/1745-6150-4-29 PMid:19706170 PMCid:PMC2743648
Olovnikov I. Chan K. Sachidanandam R. Newman D. K. Aravin A. A. Bacterial argonaute samples the transcriptome to identify foreign DNA Mol Cell 2013 51 5 594 605 DOI: 10.1016/j.molcel.2013.08.014 PMid:24034694 PMCid:PMC3809076
Hegge J. W. Swarts D. C. Oost J. van der Prokaryotic Argonaute proteins: novel genome-editing tools? Nat Rev Microbiol 2018 16 1 5 11 DOI: 10.1038/nrmicro.2017.73 PMid:28736447
Grewal S. I. RNAi-dependent formation of heterochromatin and its diverse functions Curr Opin Genet Dev 2010 20 2 134 41 DOI: 10.1016/j.gde.2010.02.003 PMid:20207534 PMCid:PMC3005588
Chan S. W. Zilberman D. Xie Z. Johansen L. K. Carrington J. C. Jacobsen S. E. RNA silencing genes control de novo DNA methylation Science 2004 303 5662 1336 DOI: 10.1126/science.1095989 PMid:14988555
Jones-Rhoades M. W. Bartel D. P. Bartel B. MicroRNAS and their regulatory roles in plants Annu Rev Plant Biol 2006 57 19 53 DOI: 10.1146/annurev.arplant.57.032905.105218 PMid:16669754
Behm-Ansmant I. Rehwinkel J. Doerks T. Stark A. Bork P. Izaurralde E. mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes Genes Dev 2006 20 14 1885 98 DOI: 10.1101/gad.1424106 PMid:16815998 PMCid:PMC1522082
Bazzini A. A. Lee M. T. Giraldez A. J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish Science 2012 336 6078 233 7 DOI: 10.1126/science.1215704 PMid:22422859 PMCid:PMC3547538
Bartel D. P. Metazoan MicroRNAs Cell 2018 173 1 20 51 DOI: 10.1016/j.cell.2018.03.006 PMid:29570994 PMCid:PMC6091663
Jonas S. Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing Nat Rev Genet 2015 16 7 421 33 DOI: 10.1038/nrg3965 PMid:26077373
Weick E. M. Miska E. A. piRNAs: from biogenesis to function Development 2014 141 18 3458 71 DOI: 10.1242/dev.094037 PMid:25183868
Cerutti H. Casas-Mollano J. A. On the origin and functions of RNA-mediated silencing: from protists to man Curr Genet 2006 50 2 81 99 DOI: 10.1007/s00294-006-0078-x PMid:16691418 PMCid:PMC2583075
Shabalina S. A. Koonin E. V. Origins and evolution of eukaryotic RNA interference Trends Ecol Evol 2008 23 10 578 87 DOI: 10.1016/j.tree.2008.06.005 PMid:18715673 PMCid:PMC2695246
Baulcombe D. RNA silencing in plants Nature 2004 431 7006 356 63 DOI: 10.1038/nature02874 PMid:15372043
Buchon N. Vaury C. RNAi: a defensive RNA-silencing against viruses and transposable elements Heredity (Edinb) 2006 96 2 195 202 DOI: 10.1038/sj.hdy.6800789 PMid:16369574
Matzke M. A. Birchler J. A. RNAi-mediated pathways in the nucleus Nat Rev Genet 2005 6 1 24 35 DOI: 10.1038/nrg1500 PMid:15630419
Plasterk R. H. RNA silencing: the genome's immune system Science 2002 296 5571 1263 5 DOI: 10.1126/science.1072148 PMid:12016302
Waterhouse P. M. Wang M. B. Lough T. Gene silencing as an adaptive defence against viruses Nature 2001 411 6839 834 42 DOI: 10.1038/35081168 PMid:11459066
Seto A. G. Kingston R. E. Lau N. C. The coming of age for Piwi proteins Mol Cell 2007 26 5 603 9 DOI: 10.1016/j.molcel.2007.05.021 PMid:17560367
Vidigal J. A. Ventura A. The biological functions of miRNAs: lessons from in vivo studies Trends Cell Biol 2015 25 3 137 47 DOI: 10.1016/j.tcb.2014.11.004 PMid:25484347 PMCid:PMC4344861
Wynant N. Santos D. Broeck J. Vanden The evolution of animal Argonautes: evidence for the absence of antiviral AGO Argonautes in vertebrates Sci Rep 2017 7 1 9230 DOI: 10.1038/s41598-017-08043-5 PMid:28835645 PMCid:PMC5569025
Sigova A. Rhind N. Zamore P. D. A single Argonaute protein mediates both transcriptional and posttranscriptional silencing in Schizosaccharomyces pombe Genes Dev 2004 18 19 2359 67 DOI: 10.1101/gad.1218004 PMid:15371329 PMCid:PMC522986
Buck A. H. Blaxter M. Functional diversification of Argonautes in nematodes: an expanding universe Biochem Soc Trans 2013 41 4 881 6 DOI: 10.1042/BST20130086 PMid:23863149 PMCid:PMC3782831
Williams R. W. Rubin G. M. ARGONAUTE1 is required for efficient RNA interference in Drosophila embryos Proc Natl Acad Sci U S A 2002 99 10 6889 94 DOI: 10.1073/pnas.072190799 PMid:12011447 PMCid:PMC124499
Okamura K. Ishizuka A. Siomi H. Siomi M. C. Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways Genes Dev 2004 18 14 1655 66 DOI: 10.1101/gad.1210204 PMid:15231716 PMCid:PMC478188
Vaucheret H. Vazquez F. Crete P. Bartel D. P. The action of ARGONAUTE1 in the miRNA pathway and its regulation by the miRNA pathway are crucial for plant development Genes Dev 2004 18 10 1187 97 DOI: 10.1101/gad.1201404 PMid:15131082 PMCid:PMC415643
Zilberman D. Cao X. Jacobsen S. E. ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation Science 2003 299 5607 716 9 DOI: 10.1126/science.1079695 PMid:12522258
Meister G. Landthaler M. Patkaniowska A. Dorsett Y. Teng G. Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs Mol Cell 2004 15 2 185 97 DOI: 10.1016/j.molcel.2004.07.007 PMid:15260970
Liu J. Carmell M. A. Rivas F. V. Marsden C. G. Thomson J. M. Song J. J. Hammond S. M. Joshua-Tor L. Hannon G. J. Argonaute2 is the catalytic engine of mammalian RNAi Science 2004 305 5689 1437 41 DOI: 10.1126/science.1102513 PMid:15284456
Hauptmann J. Dueck A. Harlander S. Pfaff J. Merkl R. Meister G. Turning catalytically inactive human Argonaute proteins into active slicer enzymes Nat Struct Mol Biol 2013 20 7 814 7 DOI: 10.1038/nsmb.2577 PMid:23665583
Nakanishi K. Ascano M. Gogakos T. Ishibe-Murakami S. Serganov A. A. Briskin D. Morozov P. Tuschl T. Patel D. J. Eukaryote-specific insertion elements control human ARGONAUTE slicer activity Cell Rep 2013 3 6 1893 900 DOI: 10.1016/j.celrep.2013.06.010 PMid:23809764 PMCid:PMC3757560
Faehnle C. R. Elkayam E. Haase A. D. Hannon G. J. Joshua-Tor L. The making of a slicer: activation of human Argonaute-1 Cell Rep 2013 3 6 1901 9 DOI: 10.1016/j.celrep.2013.05.033 PMid:23746446 PMCid:PMC3769929
Schurmann N. Trabuco L. G. Bender C. Russell R. B. Grimm D. Molecular dissection of human Argonaute proteins by DNA shuffling Nat Struct Mol Biol 2013 20 7 818 26 DOI: 10.1038/nsmb.2607 PMid:23748378
Hauptmann J. Kater L. Loffler P. Merkl R. Meister G. Generation of catalytic human Ago4 identifies structural elements important for RNA cleavage RNA 2014 20 10 1532 8 DOI: 10.1261/rna.045203.114 PMid:25114291 PMCid:PMC4174435
Hur J. K. Zinchenko M. K. Djuranovic S. Green R. Regulation of Argonaute slicer activity by guide RNA 3' end interactions with the N-terminal lobe J Biol Chem 2013 288 11 7829 40 DOI: 10.1074/jbc.M112.441030 PMid:23329841 PMCid:PMC3597821
Kwak P. B. Tomari Y. The N domain of Argonaute drives duplex unwinding during RISC assembly Nat Struct Mol Biol 2012 19 2 145 51 DOI: 10.1038/nsmb.2232 PMid:22233755
Park M. S. Phan H. D. Busch F. Hinckley S. H. Brackbill J. A. Wysocki V. H. Nakanishi K. Human Argonaute3 has slicer activity Nucleic Acids Res 2017 45 20 11867 11877 DOI: 10.1093/nar/gkx916 PMid:29040713 PMCid:PMC5714244
Lee Y. Ahn C. Han J. Choi H. Kim J. Yim J. Lee J. Provost P. Radmark O. Kim S. Kim V. N. The nuclear RNase III Drosha initiates microRNA processing Nature 2003 425 6956 415 9 DOI: 10.1038/nature01957 PMid:14508493
Nguyen T. A. Jo M. H. Choi Y. G. Park J. Kwon S. C. Hohng S. Kim V. N. Woo J. S. Functional Anatomy of the Human Microprocessor Cell 2015 161 6 1374 87 DOI: 10.1016/j.cell.2015.05.010 PMid:26027739
Yi R. Qin Y. Macara I. G. Cullen B. R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes Dev 2003 17 24 3011 6 DOI: 10.1101/gad.1158803 PMid:14681208 PMCid:PMC305252
Bernstein E. Caudy A. A. Hammond S. M. Hannon G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 2001 409 6818 363 6 DOI: 10.1038/35053110 PMid:11201747
Babiarz J. E. Ruby J. G. Wang Y. Bartel D. P. Blelloch R. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs Genes Dev 2008 22 20 2773 85 DOI: 10.1101/gad.1705308 PMid:18923076 PMCid:PMC2569885
Smardon A. Spoerke J. M. Stacey S. C. Klein M. E. Mackin N. Maine E. M. EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C elegans. Curr Biol 2000 10 4 169 78 DOI: 10.1016/S0960-9822(00)00323-7
Sijen T. Fleenor J. Simmer F. Thijssen K. L. Parrish S. Timmons L. Plasterk R. H. Fire A. On the role of RNA amplification in dsRNA-triggered gene silencing Cell 2001 107 4 465 76 DOI: 10.1016/S0092-8674(01)00576-1
Smialowska A. Djupedal I. Wang J. Kylsten P. Swoboda P. Ekwall K. RNAi mediates post-transcriptional repression of gene expression in fission yeast Schizosaccharomyces pombe Biochem Biophys Res Commun 2014 444 2 254 9 DOI: 10.1016/j.bbrc.2014.01.057 PMid:24462781
Czech B. Malone C. D. Zhou R. Stark A. Schlingeheyde C. Dus M. Perrimon N. Kellis M. Wohlschlegel J. A. Sachidanandam R. Hannon G. J. Brennecke J. An endogenous small interfering RNA pathway in Drosophila Nature 2008 453 7196 798 802 DOI: 10.1038/nature07007 PMid:18463631 PMCid:PMC2895258
Okamura K. Chung W. J. Ruby J. G. Guo H. Bartel D. P. Lai E. C. The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs Nature 2008 453 7196 803 6 DOI: 10.1038/nature07015 PMid:18463630 PMCid:PMC2735555
Ghildiyal M. Seitz H. Horwich M. D. Li C. Du T. Lee S. Xu J. Kittler E. L. Zapp M. L. Weng Z. Zamore P. D. Endogenous siRNAs derived from transposons and mRNAs in Drosophila somatic cells Science 2008 320 5879 1077 81 DOI: 10.1126/science.1157396 PMid:18403677 PMCid:PMC2953241
Watanabe T. Totoki Y. Toyoda A. Kaneda M. Kuramochi-Miyagawa S. Obata Y. Chiba H. Kohara Y. Kono T. Nakano T. Surani M. A. Sakaki Y. Sasaki H. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes Nature 2008 453 7194 539 43 DOI: 10.1038/nature06908 PMid:18404146
Kim K. Lee Y. S. Harris D. Nakahara K. Carthew R. W. The RNAi pathway initiated by Dicer-2 in Drosophila Cold Spring Harb Symp Quant Biol 2006 71 39 44 DOI: 10.1101/sqb.2006.71.008 PMid:17381278
Okamura K. Balla S. Martin R. Liu N. Lai E. C. Two distinct mechanisms generate endogenous siRNAs from bidirectional transcription in Drosophila melanogaster Nat Struct Mol Biol 2008 15 6 581 90 DOI: 10.1038/nsmb.1438 PMid:18500351 PMCid:PMC2713754
Kawamura Y. Saito K. Kin T. Ono Y. Asai K. Sunohara T. Okada T. N. Siomi M. C. Siomi H. Drosophila endogenous small RNAs bind to Argonaute 2 in somatic cells Nature 2008 453 7196 793 7 DOI: 10.1038/nature06938 PMid:18463636
Chung W. J. Okamura K. Martin R. Lai E. C. Endogenous RNA interference provides a somatic defense against Drosophila transposons Curr Biol 2008 18 11 795 802 DOI: 10.1016/j.cub.2008.05.006 PMid:18501606 PMCid:PMC2812477
Wen J. Duan H. Bejarano F. Okamura K. Fabian L. Brill J. A. Bortolamiol-Becet D. Martin R. Ruby J. G. Lai E. C. Adaptive regulation of testis gene expression and control of male fertility by the Drosophila hairpin RNA pathway [Corrected]. Mol Cell 2015 57 1 165 78 DOI: 10.1016/j.molcel.2014.11.025 PMid:25544562 PMCid:PMC4289472
Lin C. J. Hu F. Dubruille R. Vedanayagam J. Wen J. Smibert P. Loppin B. Lai E. C. The hpRNA/RNAi Pathway Is Essential to Resolve Intragenomic Conflict in the Drosophila Male Germline Dev Cell 2018 46 3 316 326 e5 DOI: 10.1016/j.devcel.2018.07.004 PMid:30086302
Tam O. H. Aravin A. A. Stein P. Girard A. Murchison E. P. Cheloufi S. Hodges E. Anger M. Sachidanandam R. Schultz R. M. Hannon G. J. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes Nature 2008 453 7194 534 8 DOI: 10.1038/nature06904 PMid:18404147 PMCid:PMC2981145
Gantier M. P. Williams B. R. The response of mammalian cells to double-stranded RNA Cytokine Growth Factor Rev 2007 18 5-6 363 71 DOI: 10.1016/j.cytogfr.2007.06.016 PMid:17698400 PMCid:PMC2084215
Maillard P. V. Veen A. G. Van der Deddouche-Grass S. Rogers N. C. Merits A. Sousa C. Reis e Inactivation of the type I interferon pathway reveals long double-stranded RNA-mediated RNA interference in mammalian cells EMBO J 2016 35 23 2505 2518 DOI: 10.15252/embj.201695086 PMid:27815315 PMCid:PMC5167344
Veen A. G. van der Maillard P. V. Schmidt J. M. Lee S. A. Deddouche-Grass S. Borg A. Kjaer S. Snijders A. P. Sousa C. Reis e The RIG-I-like receptor LGP2 inhibits Dicer-dependent processing of long double-stranded RNA and blocks RNA interference in mammalian cells EMBO J 2018 37 4 DOI: 10.15252/embj.201797479 PMid:29351913 PMCid:PMC5813259
Wianny F. Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development Nat Cell Biol 2000 2 2 70 5 DOI: 10.1038/35000016 PMid:10655585
Stein P. Zeng F. Pan H. Schultz R. M. Absence of non-specific effects of RNA interference triggered by long double-stranded RNA in mouse oocytes Dev Biol 2005 286 2 464 71 DOI: 10.1016/j.ydbio.2005.08.015 PMid:16154556
Suh N. Baehner L. Moltzahn F. Melton C. Shenoy A. Chen J. Blelloch R. MicroRNA function is globally suppressed in mouse oocytes and early embryos Curr Biol 2010 20 3 271 7 DOI: 10.1016/j.cub.2009.12.044 PMid:20116247 PMCid:PMC2872512
Ma J. Flemr M. Stein P. Berninger P. Malik R. Zavolan M. Svoboda P. Schultz R. M. MicroRNA activity is suppressed in mouse oocytes Curr Biol 2010 20 3 265 70 DOI: 10.1016/j.cub.2009.12.042 PMid:20116252 PMCid:PMC2824427
Chen L. Dahlstrom J. E. Lee S. H. Rangasamy D. Naturally occurring endo-siRNA silences LINE-1 retrotransposons in human cells through DNA methylation Epigenetics 2012 7 7 758 71 DOI: 10.4161/epi.20706 PMid:22647391
Berrens R. V. Andrews S. Spensberger D. Santos F. Dean W. Gould P. Sharif J. Olova N. Chandra T. Koseki H. Meyenn F. von Reik W. An endosiRNA-Based Repression Mechanism Counteracts Transposon Activation during Global DNA Demethylation in Embryonic Stem Cells Cell Stem Cell 2017 21 5 694 703 e7 DOI: 10.1016/j.stem.2017.10.004 PMid:29100015 PMCid:PMC5678422
Ma E. MacRae I. J. Kirsch J. F. Doudna J. A. Autoinhibition of human dicer by its internal helicase domain J Mol Biol 2008 380 1 237 43 DOI: 10.1016/j.jmb.2008.05.005 PMid:18508075 PMCid:PMC2927216
Lau P. W. Guiley K. Z. De N. Potter C. S. Carragher B. MacRae I. J. The molecular architecture of human Dicer Nat Struct Mol Biol 2012 19 4 436 40 DOI: 10.1038/nsmb.2268 PMid:22426548 PMCid:PMC3319852
Flemr M. Malik R. Franke V. Nejepinska J. Sedlacek R. Vlahovicek K. Svoboda P. A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes Cell 2013 155 4 807 16 DOI: 10.1016/j.cell.2013.10.001 PMid:24209619
Kennedy E. M. Whisnant A. W. Kornepati A. V. Marshall J. B. Bogerd H. P. Cullen B. R. Production of functional small interfering RNAs by an amino-terminal deletion mutant of human Dicer Proc Natl Acad Sci U S A 2015 112 50 E6945 54 DOI: 10.1073/pnas.1513421112 PMid:26621737 PMCid:PMC4687602
Matranga C. Tomari Y. Shin C. Bartel D. P. Zamore P. D. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes Cell 2005 123 4 607 20 DOI: 10.1016/j.cell.2005.08.044 PMid:16271386
Miyoshi K. Tsukumo H. Nagami T. Siomi H. Siomi M. C. Slicer function of Drosophila Argonautes and its involvement in RISC formation Genes Dev 2005 19 23 2837 48 DOI: 10.1101/gad.1370605 PMid:16287716 PMCid:PMC1315391
Leuschner P. J. Ameres S. L. Kueng S. Martinez J. Cleavage of the siRNA passenger strand during RISC assembly in human cells EMBO Rep 2006 7 3 314 20 DOI: 10.1038/sj.embor.7400637 PMid:16439995 PMCid:PMC1456892
Kawamata T. Seitz H. Tomari Y. Structural determinants of miRNAs for RISC loading and slicer-independent unwinding Nat Struct Mol Biol 2009 16 9 953 60 DOI: 10.1038/nsmb.1630 PMid:19684602
Yoda M. Kawamata T. Paroo Z. Ye X. Iwasaki S. Liu Q. Tomari Y. ATP-dependent human RISC assembly pathways Nat Struct Mol Biol 2010 17 1 17 23 DOI: 10.1038/nsmb.1733 PMid:19966796 PMCid:PMC2915567
Iki T. Yoshikawa M. Nishikiori M. Jaudal M. C. Matsumoto-Yokoyama E. Mitsuhara I. Meshi T. Ishikawa M. In vitro assembly of plant RNA-induced silencing complexes facilitated by molecular chaperone HSP90 Mol Cell 2010 39 2 282 91 DOI: 10.1016/j.molcel.2010.05.014 PMid:20605502
Iwasaki S. Kobayashi M. Yoda M. Sakaguchi Y. Katsuma S. Suzuki T. Tomari Y. Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes Mol Cell 2010 39 2 292 9 DOI: 10.1016/j.molcel.2010.05.015 PMid:20605501
Miyoshi T. Takeuchi A. Siomi H. Siomi M. C. A direct role for Hsp90 in pre-RISC formation in Drosophila Nat Struct Mol Biol 2010 17 8 1024 6 DOI: 10.1038/nsmb.1875 PMid:20639883
Johnston M. Geoffroy M. C. Sobala A. Hay R. Hutvagner G. HSP90 protein stabilizes unloaded argonaute complexes and microscopic P-bodies in human cells Mol Biol Cell 2010 21 9 1462 9 DOI: 10.1091/mbc.e09-10-0885 PMid:20237157 PMCid:PMC2861606
Tomari Y. Zamore P. D. Perspective: machines for RNAi Genes Dev 2005 19 5 517 29 DOI: 10.1101/gad.1284105 PMid:15741316
Meister G. Tuschl T. Mechanisms of gene silencing by double-stranded RNA Nature 2004 431 7006 343 9 DOI: 10.1038/nature02873 PMid:15372041
Schwarz D. S. Hutvagner G. Du T. Xu Z. Aronin N. Zamore P. D. Asymmetry in the assembly of the RNAi enzyme complex Cell 2003 115 2 199 208 DOI: 10.1016/S0092-8674(03)00759-1
Khvorova A. Reynolds A. Jayasena S. D. Functional siRNAs and miRNAs exhibit strand bias Cell 2003 115 2 209 16 DOI: 10.1016/S0092-8674(03)00801-8
Liu Q. Rand T. A. Kalidas S. Du F. Kim H. E. Smith D. P. Wang X. R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway Science 2003 301 5641 1921 5 DOI: 10.1126/science.1088710 PMid:14512631
Liu X. Jiang F. Kalidas S. Smith D. Liu Q. Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes RNA 2006 12 8 1514 20 DOI: 10.1261/rna.101606 PMid:16775303 PMCid:PMC1524895
Lee Y. S. Nakahara K. Pham J. W. Kim K. He Z. Sontheimer E. J. Carthew R. W. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways Cell 2004 117 1 69 81 DOI: 10.1016/S0092-8674(04)00261-2
Tomari Y. Matranga C. Haley B. Martinez N. Zamore P. D. A protein sensor for siRNA asymmetry Science 2004 306 5700 1377 80 DOI: 10.1126/science.1102755 PMid:15550672
Tomari Y. Du T. Haley B. Schwarz D. S. Bennett R. Cook H. A. Koppetsch B. S. Theurkauf W. E. Zamore P. D. RISC assembly defects in the Drosophila RNAi mutant armitage Cell 2004 116 6 831 41 DOI: 10.1016/S0092-8674(04)00218-1
Iwasaki S. Sasaki H. M. Sakaguchi Y. Suzuki T. Tadakuma H. Tomari Y. Defining fundamental steps in the assembly of the Drosophila RNAi enzyme complex Nature 2015 521 7553 533 6 DOI: 10.1038/nature14254 PMid:25822791
Pham J. W. Pellino J. L. Lee Y. S. Carthew R. W. Sontheimer E. J. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila Cell 2004 117 1 83 94 DOI: 10.1016/S0092-8674(04)00258-2
Betancur J. G. Tomari Y. Dicer is dispensable for asymmetric RISC loading in mammals RNA 2012 18 1 24 30 DOI: 10.1261/rna.029785.111 PMid:22106413 PMCid:PMC3261740
Kanellopoulou C. Muljo S. A. Kung A. L. Ganesan S. Drapkin R. Jenuwein T. Livingston D. M. Rajewsky K. Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing Genes Dev 2005 19 4 489 501 DOI: 10.1101/gad.1248505 PMid:15713842 PMCid:PMC548949
Murchison E. P. Partridge J. F. Tam O. H. Cheloufi S. Hannon G. J. Characterization of Dicer-deficient murine embryonic stem cells Proc Natl Acad Sci U S A 2005 102 34 12135 40 DOI: 10.1073/pnas.0505479102 PMid:16099834 PMCid:PMC1185572
Ye X. Huang N. Liu Y. Paroo Z. Huerta C. Li P. Chen S. Liu Q. Zhang H. Structure of C3PO and mechanism of human RISC activation Nat Struct Mol Biol 2011 18 6 650 7 DOI: 10.1038/nsmb.2032 PMid:21552258 PMCid:PMC3109212
Giraldez A. J. Mishima Y. Rihel J. Grocock R. J. Dongen S. Van Inoue K. Enright A. J. Schier A. F. Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs Science 2006 312 5770 75 9 DOI: 10.1126/science.1122689 PMid:16484454
Chendrimada T. P. Gregory R. I. Kumaraswamy E. Norman J. Cooch N. Nishikura K. Shiekhattar R. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing Nature 2005 436 7051 740 4 DOI: 10.1038/nature03868 PMid:15973356 PMCid:PMC2944926
Haase A. D. Jaskiewicz L. Zhang H. Laine S. Sack R. Gatignol A. Filipowicz W. TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing EMBO Rep 2005 6 10 961 7 DOI: 10.1038/sj.embor.7400509 PMid:16142218 PMCid:PMC1369185
Lee Y. Hur I. Park S. Y. Kim Y. K. Suh M. R. Kim V. N. The role of PACT in the RNA silencing pathway EMBO J 2006 25 3 522 32 DOI: 10.1038/sj.emboj.7600942 PMid:16424907 PMCid:PMC1383527
MacRae I. J. Ma E. Zhou M. Robinson C. V. Doudna J. A. In vitro reconstitution of the human RISC-loading complex Proc Natl Acad Sci U S A 2008 105 2 512 7 DOI: 10.1073/pnas.0710869105 PMid:18178619 PMCid:PMC2206567
Wang H. W. Noland C. Siridechadilok B. Taylor D. W. Ma E. Felderer K. Doudna J. A. Nogales E. Structural insights into RNA processing by the human RISC-loading complex Nat Struct Mol Biol 2009 16 11 1148 53 DOI: 10.1038/nsmb.1673 PMid:19820710 PMCid:PMC2845538
Gregory R. I. Chendrimada T. P. Cooch N. Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing Cell 2005 123 4 631 40 DOI: 10.1016/j.cell.2005.10.022 PMid:16271387
Forstemann K. Tomari Y. Du T. Vagin V. V. Denli A. M. Bratu D. P. Klattenhoff C. Theurkauf W. E. Zamore P. D. Normal microRNA maturation and germ-line stem cell maintenance requires Loquacious, a double-stranded RNA-binding domain protein PLoS Biol 2005 3 7 e236 DOI: 10.1371/journal.pbio.0030236 PMid:15918770 PMCid:PMC1141267
Jiang F. Ye X. Liu X. Fincher L. McKearin D. Liu Q. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila Genes Dev 2005 19 14 1674 9 DOI: 10.1101/gad.1334005 PMid:15985611 PMCid:PMC1176004
Saito K. Ishizuka A. Siomi H. Siomi M. C. Processing of pre-microRNAs by the Dicer-1-Loquacious complex in Drosophila cells PLoS Biol 2005 3 7 e235 DOI: 10.1371/journal.pbio.0030235 PMid:15918769 PMCid:PMC1141268
Noland C. L. Ma E. Doudna J. A. siRNA repositioning for guide strand selection by human Dicer complexes Mol Cell 2011 43 1 110 21 DOI: 10.1016/j.molcel.2011.05.028 PMid:21726814 PMCid:PMC3143821
Tants J. N. Fesser S. Kern T. Stehle R. Geerlof A. Wunderlich C. Juen M. Hartlmuller C. Bottcher R. Kunzelmann S. Lange O. Kreutz C. Forstemann K. Sattler M. Molecular basis for asymmetry sensing of siRNAs by the Drosophila Loqs-PD/Dcr-2 complex in RNA interference Nucleic Acids Res 2017 45 21 12536 12550 DOI: 10.1093/nar/gkx886 PMid:29040648 PMCid:PMC5716069
Seitz H. Ghildiyal M. Zamore P. D. Argonaute loading improves the 5' precision of both MicroRNAs and their miRNA* strands in flies Curr Biol 2008 18 2 147 51 DOI: 10.1016/j.cub.2007.12.049 PMid:18207740 PMCid:PMC2854039
Hu H. Y. Yan Z. Xu Y. Hu H. Menzel C. Zhou Y. H. Chen W. Khaitovich P. Sequence features associated with microRNA strand selection in humans and flies BMC Genomics 2009 10 413 DOI: 10.1186/1471-2164-10-413 PMid:19732433 PMCid:PMC2751786
Frank F. Sonenberg N. Nagar B. Structural basis for 5'-nucleotide base-specific recognition of guide RNA by human AGO2 Nature 2010 465 7299 818 22 DOI: 10.1038/nature09039 PMid:20505670
Ghildiyal M. Xu J. Seitz H. Weng Z. Zamore P. D. Sorting of Drosophila small silencing RNAs partitions microRNA* strands into the RNA interference pathway RNA 2010 16 1 43 56 DOI: 10.1261/rna.1972910 PMid:19917635 PMCid:PMC2802036
Czech B. Zhou R. Erlich Y. Brennecke J. Binari R. Villalta C. Gordon A. Perrimon N. Hannon G. J. Hierarchical rules for Argonaute loading in Drosophila Mol Cell 2009 36 3 445 56 DOI: 10.1016/j.molcel.2009.09.028 PMid:19917252 PMCid:PMC2795325
Yekta S. Shih I. H. Bartel D. P. MicroRNA-directed cleavage of HOXB8 mRNA Science 2004 304 5670 594 6 DOI: 10.1126/science.1097434 PMid:15105502
Forstemann K. Horwich M. D. Wee L. Tomari Y. Zamore P. D. Drosophila microRNAs are sorted into functionally distinct argonaute complexes after production by dicer-1 Cell 2007 130 2 287 97 DOI: 10.1016/j.cell.2007.05.056 PMid:17662943 PMCid:PMC2686109
Tomari Y. Du T. Zamore P. D. Sorting of Drosophila small silencing RNAs Cell 2007 130 2 299 308 DOI: 10.1016/j.cell.2007.05.057 PMid:17662944 PMCid:PMC2841505
Wang D. Zhang Z. O'Loughlin E. Lee T. Houel S. O'Carroll D. Tarakhovsky A. Ahn N. G. Yi R. Quantitative functions of Argonaute proteins in mammalian development Genes Dev 2012 26 7 693 704 DOI: 10.1101/gad.182758.111 PMid:22474261 PMCid:PMC3323880
Petri S. Dueck A. Lehmann G. Putz N. Rudel S. Kremmer E. Meister G. Increased siRNA duplex stability correlates with reduced off-target and elevated on-target effects RNA 2011 17 4 737 49 DOI: 10.1261/rna.2348111 PMid:21367974 PMCid:PMC3062184
Dueck A. Ziegler C. Eichner A. Berezikov E. Meister G. microRNAs associated with the different human Argonaute proteins Nucleic Acids Res 2012 40 19 9850 62 DOI: 10.1093/nar/gks705 PMid:22844086 PMCid:PMC3479175
Bartel D. P. MicroRNAs: target recognition and regulatory functions Cell 2009 136 2 215 33 DOI: 10.1016/j.cell.2009.01.002 PMid:19167326 PMCid:PMC3794896
Chi S. W. Zang J. B. Mele A. Darnell R. B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps Nature 2009 460 7254 479 86 DOI: 10.1038/nature08170 PMid:19536157 PMCid:PMC2733940
Li J. Kim T. Nutiu R. Ray D. Hughes T. R. Zhang Z. Identifying mRNA sequence elements for target recognition by human Argonaute proteins Genome Res 2014 24 5 775 85 DOI: 10.1101/gr.162230.113 PMid:24663241 PMCid:PMC4009607
Baek D. Villen J. Shin C. Camargo F. D. Gygi S. P. Bartel D. P. The impact of microRNAs on protein output Nature 2008 455 7209 64 71 DOI: 10.1038/nature07242 PMid:18668037 PMCid:PMC2745094
Selbach M. Schwanhausser B. Thierfelder N. Fang Z. Khanin R. Rajewsky N. Widespread changes in protein synthesis induced by microRNAs Nature 2008 455 7209 58 63 DOI: 10.1038/nature07228 PMid:18668040
Zielezinski A. Karlowski W. M. Early origin and adaptive evolution of the GW182 protein family, the key component of RNA silencing in animals RNA Biol 2015 12 7 761 70 DOI: 10.1080/15476286.2015.1051302 PMid:26106978 PMCid:PMC4615383
Eulalio A. Tritschler F. Izaurralde E. The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing RNA 2009 15 8 1433 42 DOI: 10.1261/rna.1703809 PMid:19535464 PMCid:PMC2714752
Ding L. Han M. GW182 family proteins are crucial for microRNA-mediated gene silencing Trends Cell Biol 2007 17 8 411 6 DOI: 10.1016/j.tcb.2007.06.003 PMid:17766119
Iwakawa H. O. Tomari Y. Molecular insights into microRNA-mediated translational repression in plants Mol Cell 2013 52 4 591 601 DOI: 10.1016/j.molcel.2013.10.033 PMid:24267452
Liu Q. Wang F. Axtell M. J. Analysis of complementarity requirements for plant microRNA targeting using a Nicotiana benthamiana quantitative transient assay Plant Cell 2014 26 2 741 53 DOI: 10.1105/tpc.113.120972 PMid:24510721 PMCid:PMC3967037
Brodersen P. Sakvarelidze-Achard L. Bruun-Rasmussen M. Dunoyer P. Yamamoto Y. Y. Sieburth L. Voinnet O. Widespread translational inhibition by plant miRNAs and siRNAs Science 2008 320 5880 1185 90 DOI: 10.1126/science.1159151 PMid:18483398
Reis R. S. Hart-Smith G. Eamens A. L. Wilkins M. R. Waterhouse P. M. Gene regulation by translational inhibition is determined by Dicer partnering proteins Nat Plants 2015 1 14027 DOI: 10.1038/nplants.2014.27 PMid:27246880
Yang L. Wu G. Poethig R. S. Mutations in the GW-repeat protein SUO reveal a developmental function for microRNA-mediated translational repression in Arabidopsis Proc Natl Acad Sci U S A 2012 109 1 315 20 DOI: 10.1073/pnas.1114673109 PMid:22184231 PMCid:PMC3252893
Zipprich J. T. Bhattacharyya S. Mathys H. Filipowicz W. Importance of the C-terminal domain of the human GW182 protein TNRC6C for translational repression RNA 2009 15 5 781 93 DOI: 10.1261/rna.1448009 PMid:19304925 PMCid:PMC2673060
Lazzaretti D. Tournier I. Izaurralde E. The C-terminal domains of human TNRC6A, TNRC6B, and TNRC6C silence bound transcripts independently of Argonaute proteins RNA 2009 15 6 1059 66 DOI: 10.1261/rna.1606309 PMid:19383768 PMCid:PMC2685519
Lian S. L. Li S. Abadal G. X. Pauley B. A. Fritzler M. J. Chan E. K. The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing RNA 2009 15 5 804 13 DOI: 10.1261/rna.1229409 PMid:19324964 PMCid:PMC2673069
Takimoto K. Wakiyama M. Yokoyama S. Mammalian GW182 contains multiple Argonaute-binding sites and functions in microRNA-mediated translational repression RNA 2009 15 6 1078 89 DOI: 10.1261/rna.1363109 PMid:19398495 PMCid:PMC2685530
Till S. Lejeune E. Thermann R. Bortfeld M. Hothorn M. Enderle D. Heinrich C. Hentze M. W. Ladurner A. G. A conserved motif in Argonaute-interacting proteins mediates functional interactions through the Argonaute PIWI domain Nat Struct Mol Biol 2007 14 10 897 903 DOI: 10.1038/nsmb1302 PMid:17891150
Elkayam E. Faehnle C. R. Morales M. Sun J. Li H. Joshua-Tor L. Multivalent Recruitment of Human Argonaute by GW182 Mol Cell 2017 67 4 646 658 e3 DOI: 10.1016/j.molcel.2017.07.007 PMid:28781232 PMCid:PMC5915679
Hauptmann J. Schraivogel D. Bruckmann A. Manickavel S. Jakob L. Eichner N. Pfaff J. Urban M. Sprunck S. Hafner M. Tuschl T. Deutzmann R. Meister G. Biochemical isolation of Argonaute protein complexes by Ago-APP Proc Natl Acad Sci U S A 2015 112 38 11841 5 DOI: 10.1073/pnas.1506116112 PMid:26351695 PMCid:PMC4586862
Wee L. M. Flores-Jasso C. F. Salomon W. E. Zamore P. D. Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties Cell 2012 151 5 1055 67 DOI: 10.1016/j.cell.2012.10.036 PMid:23178124 PMCid:PMC3595543
Denzler R. McGeary S. E. Title A. C. Agarwal V. Bartel D. P. Stoffel M. Impact of MicroRNA Levels, Target-Site Complementarity, and Cooperativity on Competing Endogenous RNA-Regulated Gene Expression Mol Cell 2016 64 3 565 579 DOI: 10.1016/j.molcel.2016.09.027 PMid:27871486 PMCid:PMC5101187
Doench J. G. Petersen C. P. Sharp P. A. siRNAs can function as miRNAs Genes Dev 2003 17 4 438 42 DOI: 10.1101/gad.1064703 PMid:12600936 PMCid:PMC195999
Pillai R. S. Artus C. G. Filipowicz W. Tethering of human Ago proteins to mRNA mimics the miRNA-mediated repression of protein synthesis RNA 2004 10 10 1518 25 DOI: 10.1261/rna.7131604 PMid:15337849 PMCid:PMC1370638
Grimson A. Farh K. K. Johnston W. K. Garrett-Engele P. Lim L. P. Bartel D. P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing Mol Cell 2007 27 1 91 105 DOI: 10.1016/j.molcel.2007.06.017 PMid:17612493 PMCid:PMC3800283
Saetrom P. Heale B. S. Snove O. Jr. Aagaard L. Alluin J. Rossi J. J. Distance constraints between microRNA target sites dictate efficacy and cooperativity Nucleic Acids Res 2007 35 7 2333 42 DOI: 10.1093/nar/gkm133 PMid:17389647 PMCid:PMC1874663
Kloosterman W. P. Wienholds E. Ketting R. F. Plasterk R. H. Substrate requirements for let-7 function in the developing zebrafish embryo Nucleic Acids Res 2004 32 21 6284 91 DOI: 10.1093/nar/gkh968 PMid:15585662 PMCid:PMC535676
Huntzinger E. Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay Nat Rev Genet 2011 12 2 99 110 DOI: 10.1038/nrg2936 PMid:21245828
Fabian M. R. Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC Nat Struct Mol Biol 2012 19 6 586 93 DOI: 10.1038/nsmb.2296 PMid:22664986
Wahle E. Winkler G. S. RNA decay machines: deadenylation by the Ccr4-not and Pan2-Pan3 complexes Biochim Biophys Acta 2013 1829 6-7 561 70 DOI: 10.1016/j.bbagrm.2013.01.003 PMid:23337855
Christie M. Boland A. Huntzinger E. Weichenrieder O. Izaurralde E. Structure of the PAN3 pseudokinase reveals the basis for interactions with the PAN2 deadenylase and the GW182 proteins Mol Cell 2013 51 3 360 73 DOI: 10.1016/j.molcel.2013.07.011 PMid:23932717
Chen Y. Boland A. Kuzuoglu-Ozturk D. Bawankar P. Loh B. Chang C. T. Weichenrieder O. Izaurralde E. A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing Mol Cell 2014 54 5 737 50 DOI: 10.1016/j.molcel.2014.03.034 PMid:24768540
Mathys H. Basquin J. Ozgur S. Czarnocki-Cieciura M. Bonneau F. Aartse A. Dziembowski A. Nowotny M. Conti E. Filipowicz W. Structural and biochemical insights to the role of the CCR4-NOT complex and DDX6 ATPase in microRNA repression Mol Cell 2014 54 5 751 65 DOI: 10.1016/j.molcel.2014.03.036 PMid:24768538
Chen C. Y. Zheng D. Xia Z. Shyu A. B. Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps Nat Struct Mol Biol 2009 16 11 1160 6 DOI: 10.1038/nsmb.1709 PMid:19838187 PMCid:PMC2921184
Braun J. E. Huntzinger E. Fauser M. Izaurralde E. GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets Mol Cell 2011 44 1 120 33 DOI: 10.1016/j.molcel.2011.09.007 PMid:21981923
Huntzinger E. Kuzuoglu-Ozturk D. Braun J. E. Eulalio A. Wohlbold L. Izaurralde E. The interactions of GW182 proteins with PABP and deadenylases are required for both translational repression and degradation of miRNA targets Nucleic Acids Res 2013 41 2 978 94 DOI: 10.1093/nar/gks1078 PMid:23172285 PMCid:PMC3553986
Siddiqui N. Mangus D. A. Chang T. C. Palermino J. M. Shyu A. B. Gehring K. Poly(A) nuclease interacts with the C-terminal domain of polyadenylate-binding protein domain from poly(A)-binding protein J Biol Chem 2007 282 34 25067 75 DOI: 10.1074/jbc.M701256200 PMid:17595167
Moretti F. Kaiser C. Zdanowicz-Specht A. Hentze M. W. PABP and the poly(A) tail augment microRNA repression by facilitated miRISC binding Nat Struct Mol Biol 2012 19 6 603 8 DOI: 10.1038/nsmb.2309 PMid:22635249
Fukaya T. Tomari Y. PABP is not essential for microRNA-mediated translational repression and deadenylation in vitro EMBO J 2011 30 24 4998 5009 DOI: 10.1038/emboj.2011.426 PMid:22117217 PMCid:PMC3243625
Mishima Y. Fukao A. Kishimoto T. Sakamoto H. Fujiwara T. Inoue K. Translational inhibition by deadenylation-independent mechanisms is central to microRNA-mediated silencing in zebrafish Proc Natl Acad Sci U S A 2012 109 4 1104 9 DOI: 10.1073/pnas.1113350109 PMid:22232654 PMCid:PMC3268308
Braun J. E. Truffault V. Boland A. Huntzinger E. Chang C. T. Haas G. Weichenrieder O. Coles M. Izaurralde E. A direct interaction between DCP1 and XRN1 couples mRNA decapping to 5' exonucleolytic degradation Nat Struct Mol Biol 2012 19 12 1324 31 DOI: 10.1038/nsmb.2413 PMid:23142987
Guo H. Ingolia N. T. Weissman J. S. Bartel D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels Nature 2010 466 7308 835 40 DOI: 10.1038/nature09267 PMid:20703300 PMCid:PMC2990499
Eichhorn S. W. Guo H. McGeary S. E. Rodriguez-Mias R. A. Shin C. Baek D. Hsu S. H. Ghoshal K. Villen J. Bartel D. P. mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues Mol Cell 2014 56 1 104 15 DOI: 10.1016/j.molcel.2014.08.028 PMid:25263593 PMCid:PMC4292926
Meijer H. A. Kong Y. W. Lu W. T. Wilczynska A. Spriggs R. V. Robinson S. W. Godfrey J. D. Willis A. E. Bushell M. Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation Science 2013 340 6128 82 5 DOI: 10.1126/science.1231197 PMid:23559250
Subtelny A. O. Eichhorn S. W. Chen G. R. Sive H. Bartel D. P. Poly(A)-tail profiling reveals an embryonic switch in translational control Nature 2014 508 7494 66 71 DOI: 10.1038/nature13007 PMid:24476825 PMCid:PMC4086860
Rocca G. La Olejniczak S. H. Gonzalez A. J. Briskin D. Vidigal J. A. Spraggon L. DeMatteo R. G. Radler M. R. Lindsten T. Ventura A. Tuschl T. Leslie C. S. Thompson C. B. In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA Proc Natl Acad Sci U S A 2015 112 3 767 72 DOI: 10.1073/pnas.1424217112 PMid:25568082 PMCid:PMC4311832
Olejniczak S. H. Rocca G. La Gruber J. J. Thompson C. B. Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses Proc Natl Acad Sci U S A 2013 110 1 157 62 DOI: 10.1073/pnas.1219958110 PMid:23248281 PMCid:PMC3538211
Olejniczak S. H. Rocca G. La Radler M. R. Egan S. M. Xiang Q. Garippa R. Thompson C. B. Coordinated Regulation of Cap-Dependent Translation and MicroRNA Function by Convergent Signaling Pathways Mol Cell Biol 2016 36 18 2360 73 DOI: 10.1128/MCB.01011-15 PMid:27354062 PMCid:PMC5007797
Bridge K. S. Shah K. M. Li Y. Foxler D. E. Wong S. C. K. Miller D. C. Davidson K. M. Foster J. G. Rose R. Hodgkinson M. R. Ribeiro P. S. Aboobaker A. A. Yashiro K. Wang X. Graves P. R. Plevin M. J. Lagos D. Sharp T. V. Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins Cell Rep 2017 20 1 173 187 DOI: 10.1016/j.celrep.2017.06.027 PMid:28683311 PMCid:PMC5507773
Fukaya T. Tomari Y. MicroRNAs mediate gene silencing via multiple different pathways in drosophila Mol Cell 2012 48 6 825 36 DOI: 10.1016/j.molcel.2012.09.024 PMid:23123195
Rivas F. V. Tolia N. H. Song J. J. Aragon J. P. Liu J. Hannon G. J. Joshua-Tor L. Purified Argonaute2 and an siRNA form recombinant human RISC Nat Struct Mol Biol 2005 12 4 340 9 DOI: 10.1038/nsmb918 PMid:15800637
Schwarz D. S. Tomari Y. Zamore P. D. The RNA-induced silencing complex is a Mg2+-dependent endonuclease Curr Biol 2004 14 9 787 91 DOI: 10.1016/j.cub.2004.03.008 PMid:15120070
Elbashir S. M. Martinez J. Patkaniowska A. Lendeckel W. Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate EMBO J 2001 20 23 6877 88 DOI: 10.1093/emboj/20.23.6877 PMid:11726523 PMCid:PMC125328
Ma J. B. Yuan Y. R. Meister G. Pei Y. Tuschl T. Patel D. J. Structural basis for 5'-end-specific recognition of guide RNA by the A fulgidus Piwi protein. Nature 2005 434 7033 666 70 DOI: 10.1038/nature03514 PMid:15800629 PMCid:PMC4694588
Deerberg A. Willkomm S. Restle T. Minimal mechanistic model of siRNA-dependent target RNA slicing by recombinant human Argonaute 2 protein Proc Natl Acad Sci U S A 2013 110 44 17850 5 DOI: 10.1073/pnas.1217838110 PMid:24101500 PMCid:PMC3816469
Bernstein E. Kim S. Y. Carmell M. A. Murchison E. P. Alcorn H. Li M. Z. Mills A. A. Elledge S. J. Anderson K. V. Hannon G. J. Dicer is essential for mouse development Nat Genet 2003 35 3 215 7 DOI: 10.1038/ng1103-287b DOI: 10.1038/ng1253 PMid:14528307
Murchison E. P. Stein P. Xuan Z. Pan H. Zhang M. Q. Schultz R. M. Hannon G. J. Critical roles for Dicer in the female germline Genes Dev 2007 21 6 682 93 DOI: 10.1101/gad.1521307 PMid:17369401 PMCid:PMC1820942
Wang Y. Medvid R. Melton C. Jaenisch R. Blelloch R. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal Nat Genet 2007 39 3 380 5 DOI: 10.1038/ng1969 PMid:17259983 PMCid:PMC3008549
Cheloufi S. Santos C. O. Dos Chong M. M. Hannon G. J. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis Nature 2010 465 7298 584 9 DOI: 10.1038/nature09092 PMid:20424607 PMCid:PMC2995450
Papapetrou E. P. Korkola J. E. Sadelain M. A genetic strategy for single and combinatorial analysis of miRNA function in mammalian hematopoietic stem cells Stem Cells 2010 28 2 287 96 DOI: 10.1002/stem.257 PMid:19911427
Cifuentes D. Xue H. Taylor D. W. Patnode H. Mishima Y. Cheloufi S. Ma E. Mane S. Hannon G. J. Lawson N. D. Wolfe S. A. Giraldez A. J. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity Science 2010 328 5986 1694 8 DOI: 10.1126/science.1190809 PMid:20448148 PMCid:PMC3093307
Jee D. Yang J. S. Park S. M. Farmer D. T. Wen J. Chou T. Chow A. McManus M. T. Kharas M. G. Lai E. C. Dual Strategies for Argonaute2-Mediated Biogenesis of Erythroid miRNAs Underlie Conserved Requirements for Slicing in Mammals Mol Cell 2018 69 2 265 278 e6 DOI: 10.1016/j.molcel.2017.12.027 PMid:29351846 PMCid:PMC5824974
Kaneda M. Tang F. O'Carroll D. Lao K. Surani M. A. Essential role for Argonaute2 protein in mouse oogenesis Epigenetics Chromatin 2009 2 1 9 DOI: 10.1186/1756-8935-2-9 PMid:19664249 PMCid:PMC2736168
Stein P. Rozhkov N. V. Li F. Cardenas F. L. Davydenko O. Vandivier L. E. Gregory B. D. Hannon G. J. Schultz R. M. Essential Role for endogenous siRNAs during meiosis in mouse oocytes PLoS Genet 2015 11 2 e1005013 DOI: 10.1371/journal.pgen.1005013 PMid:25695507 PMCid:PMC4335007
Watanabe dT. Takeda A. Tsukiyama T. Mise K. Okuno T. Sasaki H. Minami N. Imai H. Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes Genes Dev 2006 20 13 1732 43 DOI: 10.1101/gad.1425706 PMid:16766679 PMCid:PMC1522070
Svoboda P. Stein P. Anger M. Bernstein E. Hannon G. J. Schultz R. M. RNAi and expression of retrotransposons MuERV-L and IAP in preimplantation mouse embryos Dev Biol 2004 269 1 276 85 DOI: 10.1016/j.ydbio.2004.01.028 PMid:15081373
Damiani D. Alexander J. J. O'Rourke J. R. McManus M. Jadhav A. P. Cepko C. L. Hauswirth W. W. Harfe B. D. Strettoi E. Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina J Neurosci 2008 28 19 4878 87 DOI: 10.1523/JNEUROSCI.0828-08.2008 PMid:18463241 PMCid:PMC3325486
Huang C. Wang X. Liu X. Cao S. Shan G. RNAi pathway participates in chromosome segregation in mammalian cells Cell Discov 2015 1 15029 DOI: 10.1038/celldisc.2015.29 PMid:27462427 PMCid:PMC4860838
Pek J. W. Kai T. DEAD-box RNA helicase Belle/DDX3 and the RNA interference pathway promote mitotic chromosome segregation Proc Natl Acad Sci U S A 2011 108 29 12007 12 DOI: 10.1073/pnas.1106245108 PMid:21730191 PMCid:PMC3141994
Shin C. Nam J. W. Farh K. K. Chiang H. R. Shkumatava A. Bartel D. P. Expanding the microRNA targeting code: functional sites with centered pairing Mol Cell 2010 38 6 789 802 DOI: 10.1016/j.molcel.2010.06.005 PMid:20620952 PMCid:PMC2942757
Karginov F. V. Cheloufi S. Chong M. M. Stark A. Smith A. D. Hannon G. J. Diverse endonucleolytic cleavage sites in the mammalian transcriptome depend upon microRNAs, Drosha, and additional nucleases Mol Cell 2010 38 6 781 8 DOI: 10.1016/j.molcel.2010.06.001 PMid:20620951 PMCid:PMC2914474
Davis E. Caiment F. Tordoir X. Cavaille J. Ferguson-Smith A. Cockett N. Georges M. Charlier C. RNAi-mediated allelic trans-interaction at the imprinted Rtl1/Peg11 locus Curr Biol 2005 15 8 743 9 DOI: 10.1016/j.cub.2005.02.060 PMid:15854907
He X. Yan Y. L. Eberhart J. K. Herpin A. Wagner T. U. Schartl M. Postlethwait J. H. miR-196 regulates axial patterning and pectoral appendage initiation Dev Biol 2011 357 2 463 77 DOI: 10.1016/j.ydbio.2011.07.014 PMid:21787766 PMCid:PMC3164755
Liu J. Valencia-Sanchez M. A. Hannon G. J. Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies Nat Cell Biol 2005 7 7 719 23 DOI: 10.1038/ncb1274 PMid:15937477 PMCid:PMC1855297
Luo Y. Na Z. Slavoff S. A. P-Bodies: Composition, Properties, and Functions Biochemistry 2018 57 17 2424 2431 DOI: 10.1021/acs.biochem.7b01162 PMid:29381060 PMCid:PMC6296482
Gagnon K. T. Li L. Chu Y. Janowski B. A. Corey D. R. RNAi factors are present and active in human cell nuclei Cell Rep 2014 6 1 211 21 DOI: 10.1016/j.celrep.2013.12.013 PMid:24388755 PMCid:PMC3916906
Gagnon K. T. Li L. Janowski B. A. Corey D. R. Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading Nat Protoc 2014 9 9 2045 60 DOI: 10.1038/nprot.2014.135 PMid:25079428 PMCid:PMC4251768
Sharma N. R. Wang X. Majerciak V. Ajiro M. Kruhlak M. Meyers C. Zheng Z. M. Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2 J Biol Chem 2016 291 5 2302 9 DOI: 10.1074/jbc.C115.695049 PMid:26699195 PMCid:PMC4732213
Zamudio J. R. Kelly T. J. Sharp P. A. Argonaute-bound small RNAs from promoter-proximal RNA polymerase II Cell 2014 156 5 920 34 DOI: 10.1016/j.cell.2014.01.041 PMid:24581493 PMCid:PMC4111103
Claycomb J. M. Batista P. J. Pang K. M. Gu W. Vasale J. J. Wolfswinkel J. C. van Chaves D. A. Shirayama M. Mitani S. Ketting R. F. Conte D. Jr. Mello C. C. The Argonaute CSR-1 and its 22G-RNA cofactors are required for holocentric chromosome segregation Cell 2009 139 1 123 34 DOI: 10.1016/j.cell.2009.09.014 PMid:19804758 PMCid:PMC2766185
Taliaferro J. M. Aspden J. L. Bradley T. Marwha D. Blanchette M. Rio D. C. Two new and distinct roles for Drosophila Argonaute-2 in the nucleus: alternative pre-mRNA splicing and transcriptional repression Genes Dev 2013 27 4 378 89 DOI: 10.1101/gad.210708.112 PMid:23392611 PMCid:PMC3589555
Qi Y. He X. Wang X. J. Kohany O. Jurka J. Hannon G. J. Distinct catalytic and non-catalytic roles of ARGONAUTE4 in RNA-directed DNA methylation Nature 2006 443 7114 1008 12 DOI: 10.1038/nature05198 PMid:16998468
Pushpavalli S. N. Sarkar A. Bag I. Hunt C. R. Ramaiah M. J. Pandita T. K. Bhadra U. Pal-Bhadra M. Argonaute-1 functions as a mitotic regulator by controlling Cyclin B during Drosophila early embryogenesis FASEB J 2014 28 2 655 66 DOI: 10.1096/fj.13-231167 PMid:24165481 PMCid:PMC6191000
Oliver C. Santos J. L. Pradillo M. Accurate Chromosome Segregation at First Meiotic Division Requires AGO4, a Protein Involved in RNA-Dependent DNA Methylation in Arabidopsis thaliana Genetics 2016 204 2 543 553 DOI: 10.1534/genetics.116.189217 PMid:27466226 PMCid:PMC5068845
Durand-Dubief M. Bastin P. TbAGO1, an argonaute protein required for RNA interference, is involved in mitosis and chromosome segregation in Trypanosoma brucei BMC Biol 2003 1 2
Yigit E. Batista P. J. Bei Y. Pang K. M. Chen C. C. Tolia N. H. Joshua-Tor L. Mitani S. Simard M. J. Mello C. C. Analysis of the C elegans Argonaute family reveals that distinct Argonautes act sequentially during RNAi. Cell 2006 127 4 747 57 DOI: 10.1016/j.cell.2006.09.033 PMid:17110334
Gerson-Gurwitz A. Wang S. Sathe S. Green R. Yeo G. W. Oegema K. Desai A. A Small RNA-Catalytic Argonaute Pathway Tunes Germline Transcript Levels to Ensure Embryonic Divisions Cell 2016 165 2 396 409 DOI: 10.1016/j.cell.2016.02.040 PMid:27020753 PMCid:PMC4826293
Yashiro R. Murota Y. Nishida K. M. Yamashiro H. Fujii K. Ogai A. Yamanaka S. Negishi L. Siomi H. Siomi M. C. Piwi Nuclear Localization and Its Regulatory Mechanism in Drosophila Ovarian Somatic Cells Cell Rep 2018 23 12 3647 3657 DOI: 10.1016/j.celrep.2018.05.051 PMid:29925005
Sarshad A. A. Juan A. H. Muler A. I. C. Anastasakis D. G. Wang X. Genzor P. Feng X. Tsai P. F. Sun H. W. Haase A. D. Sartorelli V. Hafner M. Argonaute-miRNA Complexes Silence Target mRNAs in the Nucleus of Mammalian Stem Cells Mol Cell 2018 71 6 1040 1050 e8 DOI: 10.1016/j.molcel.2018.07.020 PMid:30146314
Allo M. Buggiano V. Fededa J. P. Petrillo E. Schor I. Mata M. de la Agirre E. Plass M. Eyras E. Elela S. A. Klinck R. Chabot B. Kornblihtt A. R. Control of alternative splicing through siRNA-mediated transcriptional gene silencing Nat Struct Mol Biol 2009 16 7 717 24 DOI: 10.1038/nsmb.1620 PMid:19543290
Allo M. Agirre E. Bessonov S. Bertucci P. Acuna L. Gomez Buggiano V. Bellora N. Singh B. Petrillo E. Blaustein M. Minana B. Dujardin G. Pozzi B. Pelisch F. Bechara E. Agafonov D. E. Srebrow A. Luhrmann R. Valcarcel J. Eyras E. Kornblihtt A. R. Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells Proc Natl Acad Sci U S A 2014 111 44 15622 9 DOI: 10.1073/pnas.1416858111 PMid:25313066 PMCid:PMC4226100
Benhamed M. Herbig U. Ye T. Dejean A. Bischof O. Senescence is an endogenous trigger for microRNA-directed transcriptional gene silencing in human cells Nat Cell Biol 2012 14 3 266 75 DOI: 10.1038/ncb2443 PMid:22366686 PMCid:PMC5423543
Ahlenstiel C. L. Lim H. G. Cooper D. A. Ishida T. Kelleher A. D. Suzuki K. Direct evidence of nuclear Argonaute distribution during transcriptional silencing links the actin cytoskeleton to nuclear RNAi machinery in human cells Nucleic Acids Res 2012 40 4 1579 95 DOI: 10.1093/nar/gkr891 PMid:22064859 PMCid:PMC3287199
Janowski B. A. Huffman K. E. Schwartz J. C. Ram R. Nordsell R. Shames D. S. Minna J. D. Corey D. R. Involvement of AGO1 and AGO2 in mammalian transcriptional silencing Nat Struct Mol Biol 2006 13 9 787 92 DOI: 10.1038/nsmb1140 PMid:16936728
Huang V. Zheng J. Qi Z. Wang J. Place R. F. Yu J. Li H. Li L. C. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells PLoS Genet 2013 9 9 e1003821 DOI: 10.1371/journal.pgen.1003821 PMid:24086155 PMCid:PMC3784563
Li L. C. Okino S. T. Zhao H. Pookot D. Place R. F. Urakami S. Enokida H. Dahiya R. Small dsRNAs induce transcriptional activation in human cells Proc Natl Acad Sci U S A 2006 103 46 17337 42 DOI: 10.1073/pnas.0607015103 PMid:17085592 PMCid:PMC1859931
Robb G. B. Brown K. M. Khurana J. Rana T. M. Specific and potent RNAi in the nucleus of human cells Nat Struct Mol Biol 2005 12 2 133 7 DOI: 10.1038/nsmb886 PMid:15643423
Meister G. Argonaute proteins: functional insights and emerging roles Nat Rev Genet 2013 14 7 447 59 DOI: 10.1038/nrg3462 PMid:23732335
Fasanaro P. Greco S. Lorenzi M. Pescatori M. Brioschi M. Kulshreshtha R. Banfi C. Stubbs A. Calin G. A. Ivan M. Capogrossi M. C. Martelli F. An integrated approach for experimental target identification of hypoxia-induced miR-210 J Biol Chem 2009 284 50 35134 43 DOI: 10.1074/jbc.M109.052779 PMid:19826008 PMCid:PMC2787374
Hansen T. B. Wiklund E. D. Bramsen J. B. Villadsen S. B. Statham A. L. Clark S. J. Kjems J. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA EMBO J 2011 30 21 4414 22 DOI: 10.1038/emboj.2011.359 PMid:21964070 PMCid:PMC3230379
Leucci E. Patella F. Waage J. Holmstrom K. Lindow M. Porse B. Kauppinen S. Lund A. H. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus Sci Rep 2013 3 2535 DOI: 10.1038/srep02535 PMid:23985560 PMCid:PMC3756333
Nishi K. Nishi A. Nagasawa T. Ui-Tei K. Human TNRC6A is an Argonaute-navigator protein for microRNA-mediated gene silencing in the nucleus RNA 2013 19 1 17 35 DOI: 10.1261/rna.034769.112 PMid:23150874 PMCid:PMC3527724
Weinmann L. Hock J. Ivacevic T. Ohrt T. Mutze J. Schwille P. Kremmer E. Benes V. Urlaub H. Meister G. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs Cell 2009 136 3 496 507 DOI: 10.1016/j.cell.2008.12.023 PMid:19167051
Ye R. Wang W. Iki T. Liu C. Wu Y. Ishikawa M. Zhou X. Qi Y. Cytoplasmic assembly and selective nuclear import of Arabidopsis Argonaute4/siRNA complexes Mol Cell 2012 46 6 859 70 DOI: 10.1016/j.molcel.2012.04.013 PMid:22608924
Olivieri D. Sykora M. M. Sachidanandam R. Mechtler K. Brennecke J. An in vivo RNAi assay identifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila EMBO J 2010 29 19 3301 17 DOI: 10.1038/emboj.2010.212 PMid:20818334 PMCid:PMC2957214
Reuter M. Chuma S. Tanaka T. Franz T. Stark A. Pillai R. S. Loss of the Mili-interacting Tudor domain-containing protein-1 activates transposons and alters the Mili-associated small RNA profile Nat Struct Mol Biol 2009 16 6 639 46 DOI: 10.1038/nsmb.1615 PMid:19465913
Xiol J. Cora E. Koglgruber R. Chuma S. Subramanian S. Hosokawa M. Reuter M. Yang Z. Berninger P. Palencia A. Benes V. Penninger J. Sachidanandam R. Pillai R. S. A role for Fkbp6 and the chaperone machinery in piRNA amplification and transposon silencing Mol Cell 2012 47 6 970 9 DOI: 10.1016/j.molcel.2012.07.019 PMid:22902560
Su H. Trombly M. I. Chen J. Wang X. Essential and overlapping functions for mammalian Argonautes in microRNA silencing Genes Dev 2009 23 3 304 17 DOI: 10.1101/gad.1749809 PMid:19174539 PMCid:PMC2648544
Modzelewski A. J. Holmes R. J. Hilz S. Grimson A. Cohen P. E. AGO4 regulates entry into meiosis and influences silencing of sex chromosomes in the male mouse germline Dev Cell 2012 23 2 251 64 DOI: 10.1016/j.devcel.2012.07.003 PMid:22863743 PMCid:PMC3470808
Stry M. Van Oguin T. H. 3rd Cheloufi S. Vogel P. Watanabe M. Pillai M. R. Dash P. Thomas P. G. Hannon G. J. Bix M. Enhanced susceptibility of Ago1/3 double-null mice to influenza A virus infection J Virol 2012 86 8 4151 7 DOI: 10.1128/JVI.05303-11 PMid:22318144 PMCid:PMC3318639
Kuscu C. Kumar P. Kiran M. Su Z. Malik A. Dutta A. tRNA fragments (tRFs) guide Ago to regulate gene expression post-transcriptionally in a Dicer-independent manner RNA 2018 24 8 1093 1105 DOI: 10.1261/rna.066126.118 PMid:29844106
Shigematsu M. Kirino Y. tRNA-Derived Short Non-coding RNA as Interacting Partners of Argonaute Proteins Gene Regul Syst Bio 2015 9 27 33 DOI: 10.4137/GRSB.S29411 PMid:26401098 PMCid:PMC4567038
Kumar P. Anaya J. Mudunuri S. B. Dutta A. Meta-analysis of tRNA derived RNA fragments reveals that they are evolutionarily conserved and associate with AGO proteins to recognize specific RNA targets BMC Biol 2014 12 78 DOI: 10.1186/PREACCEPT-5867533061403216 PMid:25270025 PMCid:PMC4203973
Ngondo R. P. Cirera-Salinas D. Yu J. Wischnewski H. Bodak M. Vandormael-Pournin S. Geiselmann A. Wettstein R. Luitz J. Cohen-Tannoudji M. Ciaudo C. Argonaute 2 Is Required for Extra-embryonic Endoderm Differentiation of Mouse Embryonic Stem Cells Stem Cell Reports 2018 10 2 461 476 DOI: 10.1016/j.stemcr.2017.12.023 PMid:29396181 PMCid:PMC5830960
Koesters R. Adams V. Betts D. Moos R. Schmid M. Siermann A. Hassam S. Weitz S. Lichter P. Heitz P. U. Doeberitz M. von Knebel Briner J. Human eukaryotic initiation factor EIF2C1 gene: cDNA sequence, genomic organization, localization to chromosomal bands 1p34-p35, and expression Genomics 1999 61 2 210 8 DOI: 10.1006/geno.1999.5951 PMid:10534406
Dome J. S. Coppes M. J. Recent advances in Wilms tumor genetics Curr Opin Pediatr 2002 14 1 5 11 DOI: 10.1097/00008480-200202000-00002 PMid:11880727
Treger T. D. Chowdhury T. Pritchard-Jones K. Behjati S. The genetic changes of Wilms tumour Nat Rev Nephrol 2019 15 4 240 251 DOI: 10.1038/s41581-019-0112-0 PMid:30705419
Torrezan G. T. Ferreira E. N. Nakahata A. M. Barros B. D. Castro M. T. Correa B. R. Krepischi A. C. Olivieri E. H. Cunha I. W. Tabori U. Grundy P. E. Costa C. M. Camargo B. de Galante P. A. Carraro D. M. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour Nat Commun 2014 5 4039 DOI: 10.1038/ncomms5039 PMid:24909261 PMCid:PMC4062040
Rakheja D. Chen K. S. Liu Y. Shukla A. A. Schmid V. Chang T. C. Khokhar S. Wickiser J. E. Karandikar N. J. Malter J. S. Mendell J. T. Amatruda J. F. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours Nat Commun 2014 2 4802 DOI: 10.1158/1538-7445.AM2014-LB-204
Walz A. L. Ooms A. Gadd S. Gerhard D. S. Smith M. A. Auvil J. M. Guidry Meerzaman D. Chen Q. R. Hsu C. H. Yan C. Nguyen C. Hu Y. Bowlby R. Brooks D. Ma Y. Mungall A. J. Moore R. A. Schein J. Marra M. A. Huff V. Dome J. S. Chi Y. Y. Mullighan C. G. Ma J. Wheeler D. A. Hampton O. A. Jafari N. Ross N. Gastier-Foster J. M. Perlman E. J. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors Cancer Cell 2015 27 2 286 97 DOI: 10.1016/j.ccell.2015.01.003 PMid:25670082 PMCid:PMC4800737
Wegert J. Ishaque N. Vardapour R. Georg C. Gu Z. Bieg M. Ziegler B. Bausenwein S. Nourkami N. Ludwig N. Keller A. Grimm C. Kneitz S. Williams R. D. Chagtai T. Pritchard-Jones K. Sluis P. van Volckmann R. Koster J. Versteeg R. Acha T. O'Sullivan M. J. Bode P. K. Niggli F. Tytgat G. A. Tinteren H. van Heuvel-Eibrink M. M. van den Meese E. Vokuhl C. Leuschner I. Graf N. Eils R. Pfister S. M. Kool M. Gessler M. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors Cancer Cell 2015 27 2 298 311 DOI: 10.1016/j.ccell.2015.01.002 PMid:25670083
Carmell M. A. Xuan Z. Zhang M. Q. Hannon G. J. The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis Genes Dev 2002 16 21 2733 42 DOI: 10.1101/gad.1026102 PMid:12414724
Tokita M. J. Chow P. M. Mirzaa G. Dikow N. Maas B. Isidor B. Caignec C. Le Penney L. S. Mazzotta G. Bernardini L. Filippi T. Battaglia A. Donti E. Earl D. Prontera P. Five children with deletions of 1p34.3 encompassing AGO1 and AGO3. Eur J Hum Genet 2015 23 6 761 5 DOI: 10.1038/ejhg.2014.202 PMid:25271087 PMCid:PMC4795073
Li L. Yu C. Gao H. Li Y. Argonaute proteins: potential biomarkers for human colon cancer BMC Cancer 2010 10 38 DOI: 10.1186/1471-2407-10-38 PMid:20146808 PMCid:PMC2843668
Chang S. S. Smith I. Glazer C. Hennessey P. Califano J. A. EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma ORL J Otorhinolaryngol Relat Spec 2010 72 6 337 43 DOI: 10.1159/000320597 PMid:20924207 PMCid:PMC2975733
Yang F. Q. Huang J. H. Liu M. Yang F. P. Li W. Wang G. C. Che J. P. Zheng J. H. Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder Int J Clin Exp Pathol 2014 7 1 340 7
Vaksman O. Hetland T. E. Trope C. G. Reich R. Davidson B. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma Hum Pathol 2012 43 11 2062 9 DOI: 10.1016/j.humpath.2012.02.016 PMid:22647351
Zhang J. Fan X. S. Wang C. X. Liu B. Li Q. Zhou X. J. Up-regulation of Ago2 expression in gastric carcinoma Med Oncol 2013 30 3 628 DOI: 10.1007/s12032-013-0628-2 PMid:23775134
Papachristou D. J. Korpetinou A. Giannopoulou E. Antonacopoulou A. G. Papadaki H. Grivas P. Scopa C. D. Kalofonos H. P. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas Virchows Arch 2011 459 4 431 40 DOI: 10.1007/s00428-011-1119-5 PMid:21769619
Feng B. Hu P. Lu S. J. Chen J. B. Ge R. L. Increased argonaute 2 expression in gliomas and its association with tumor progression and poor prognosis Asian Pac J Cancer Prev 2014 15 9 4079 83 DOI: 10.7314/APJCP.2014.15.9.4079 PMid:24935600
Zhang J. Jin H. Liu H. Lv S. Wang B. Wang R. Liu H. Ding M. Yang Y. Li L. Zhang J. Fu S. Xie D. Wu M. Zhou W. Qian Q. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma Oncogenesis 2014 3 e97 DOI: 10.1038/oncsis.2014.11 PMid:24732044 PMCid:PMC4007193
Shen J. Xia W. Khotskaya Y. B. Huo L. Nakanishi K. Lim S. O. Du Y. Wang Y. Chang W. C. Chen C. H. Hsu J. L. Wu Y. Lam Y. C. James B. P. Liu X. Liu C. G. Patel D. J. Hung M. C. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 Nature 2013 497 7449 383 7 DOI: 10.1038/nature12080 PMid:23636329 PMCid:PMC3717558
Horman S. R. Janas M. M. Litterst C. Wang B. MacRae I. J. Sever M. J. Morrissey D. V. Graves P. Luo B. Umesalma S. Qi H. H. Miraglia L. J. Novina C. D. Orth A. P. Akt-mediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of MicroRNA targets Mol Cell 2013 50 3 356 67 DOI: 10.1016/j.molcel.2013.03.015 PMid:23603119 PMCid:PMC3654076
Altomare D. A. Testa J. R. Perturbations of the AKT signaling pathway in human cancer Oncogene 2005 24 50 7455 64 DOI: 10.1038/sj.onc.1209085 PMid:16288292
Golden R. J. Chen B. Li T. Braun J. Manjunath H. Chen X. Wu J. Schmid V. Chang T. C. Kopp F. Ramirez-Martinez A. Tagliabracci V. S. Chen Z. J. Xie Y. Mendell J. T. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing Nature 2017 542 7640 197 202 DOI: 10.1038/nature21025 PMid:28114302 PMCid:PMC5302127
Rudel S. Wang Y. Lenobel R. Korner R. Hsiao H. H. Urlaub H. Patel D. Meister G. Phosphorylation of human Argonaute proteins affects small RNA binding Nucleic Acids Res 2011 39 6 2330 43 DOI: 10.1093/nar/gkq1032 PMid:21071408 PMCid:PMC3064767
Qi H. H. Ongusaha P. P. Myllyharju J. Cheng D. Pakkanen O. Shi Y. Lee S. W. Peng J. Shi Y. Prolyl 4-hydroxylation regulates Argonaute 2 stability Nature 2008 455 7211 421 4 DOI: 10.1038/nature07186 PMid:18690212 PMCid:PMC2661850
Leung A. Todorova T. Ando Y. Chang P. Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm RNA Biol 2012 9 5 542 8 DOI: 10.4161/rna.19899 PMid:22531498 PMCid:PMC3495734
Shekar P. C. Naim A. Sarathi D. P. Kumar S. Argonaute-2-null embryonic stem cells are retarded in self-renewal and differentiation J Biosci 2011 36 4 649 57 DOI: 10.1007/s12038-011-9094-1 PMid:21857111
Morita S. Horii T. Kimura M. Goto Y. Ochiya T. Hatada I. One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation Genomics 2007 89 6 687 96 DOI: 10.1016/j.ygeno.2007.01.004 PMid:17418524
Alisch R. S. Jin P. Epstein M. Caspary T. Warren S. T. Argonaute2 is essential for mammalian gastrulation and proper mesoderm formation PLoS Genet 2007 3 12 e227 DOI: 10.1371/journal.pgen.0030227 PMid:18166081 PMCid:PMC2323323
Back to top